10-Q 1 bhf-20190331x10q.htm 10-Q Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
  
FORM 10-Q
 
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
or
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___ to ___                    
Commission File Number: 001-37905
 
bhflogorgb970pxa24.jpg
Brighthouse Financial, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
81-3846992
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
11225 North Community House Road, Charlotte, North Carolina
 
28277
(Address of principal executive offices)
 
(Zip Code)
(980) 365-7100
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ  No ¨   
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes þ    No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ
  
Accelerated filer  ¨
Non-accelerated filer    ¨
  
Smaller reporting company  ¨
Emerging growth company  ¨
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ¨    No þ
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
BHF
The Nasdaq Stock Market LLC
Depositary Shares, each representing a 1/1,000th interest in a share of 6.600% Non-Cumulative Preferred Stock, Series A
BHFAP
The Nasdaq Stock Market LLC
6.250% Junior Subordinated Debentures due 2058
BHFAL
The Nasdaq Stock Market LLC
As of May 3, 2019, 115,809,697 shares of the registrant’s common stock were outstanding.
 
 


Table of Contents
 
Page
 
   Item 1.
Consolidated Financial Statements (at March 31, 2019 (Unaudited) and December 31, 2018 and for the Three Months Ended March 31, 2019 and 2018 (Unaudited)):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Item 2.
  Item 3.
  Item 4.
 
 
 
  Item 1.
  Item 1A.
  Item 2.
  Item 5.
  Item 6.
 
 


Part I — Financial Information
Item 1. Financial Statements
Brighthouse Financial, Inc.
Interim Condensed Consolidated Balance Sheets
March 31, 2019 (Unaudited) and December 31, 2018
(In millions, except share and per share data)
 
 
March 31, 2019
 
December 31, 2018
Assets
 
 
 
 
Investments:
 
 
 
 
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $61,101 and $60,920, respectively)
 
$
64,847

 
$
62,608

Equity securities, at estimated fair value
 
150

 
140

Mortgage loans (net of valuation allowances of $60 and $57, respectively)
 
14,504

 
13,694

Policy loans
 
1,385

 
1,421

Real estate limited partnerships and limited liability companies
 
453

 
451

Other limited partnership interests
 
1,800

 
1,840

Short-term investments, principally at estimated fair value
 
799

 
—

Other invested assets, principally at estimated fair value
 
2,302

 
3,027

Total investments
 
86,240

 
83,181

Cash and cash equivalents
 
3,864

 
4,145

Accrued investment income
 
791

 
724

Premiums, reinsurance and other receivables
 
14,026

 
13,697

Deferred policy acquisition costs and value of business acquired
 
5,680

 
5,717

Current income tax recoverable
 
—

 
1

Other assets
 
618

 
573

Separate account assets
 
105,211

 
98,256

Total assets
 
$
216,430

 
$
206,294

Liabilities and Equity
 
 
 
 
Liabilities
 
 
 
 
Future policy benefits
 
$
37,157

 
$
36,209

Policyholder account balances
 
41,177

 
40,054

Other policy-related balances
 
3,005

 
3,000

Payables for collateral under securities loaned and other transactions
 
3,990

 
5,057

Long-term debt
 
4,364

 
3,963

Current income tax payable
 
19

 
15

Deferred income tax liability
 
1,005

 
972

Other liabilities
 
5,438

 
4,285

Separate account liabilities
 
105,211

 
98,256

Total liabilities
 
201,366

 
191,811

Contingencies, Commitments and Guarantees (Note 11)
 

 

Equity
 
 
 
 
Brighthouse Financial, Inc.’s stockholders’ equity:
 
 
 
 
Preferred stock, par value $0.01 per share; $425 aggregate liquidation preference at March 31, 2019
 
—

 
—

Common stock, par value $0.01 per share; 1,000,000,000 shares authorized; 120,552,514 and 120,448,018 shares issued, respectively; 116,182,687 and 117,532,336 shares outstanding, respectively
 
1

 
1

Additional paid-in capital
 
12,889

 
12,473

Retained earnings (deficit)
 
609

 
1,346

Treasury stock, at cost; 4,369,827 and 2,915,682 shares, respectively
 
(170
)
 
(118
)
Accumulated other comprehensive income (loss)
 
1,670

 
716

Total Brighthouse Financial, Inc.’s stockholders’ equity
 
14,999

 
14,418

Noncontrolling interests
 
65

 
65

Total equity
 
15,064

 
14,483

Total liabilities and equity
 
$
216,430

 
$
206,294

See accompanying notes to the interim condensed consolidated financial statements.

2

Brighthouse Financial, Inc.
Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
For the Three Months Ended March 31, 2019 and 2018 (Unaudited)
(In millions, except per share data)
 
Three Months Ended
 March 31,
 
2019
 
2018
Revenues
 
 
 
Premiums
$
227

 
$
229

Universal life and investment-type product policy fees
875

 
1,002

Net investment income
811

 
817

Other revenues
92

 
105

Net investment gains (losses)
(11
)
 
(4
)
Net derivative gains (losses)
(1,303
)
 
(334
)
Total revenues
691

 
1,815

Expenses
 
 
 
Policyholder benefits and claims
772

 
738

Interest credited to policyholder account balances
258

 
267

Amortization of deferred policy acquisition costs and value of business acquired
22

 
305

Other expenses
592

 
618

Total expenses
1,644

 
1,928

Income (loss) before provision for income tax
(953
)
 
(113
)
Provision for income tax expense (benefit)
(218
)
 
(48
)
Net income (loss)
(735
)
 
(65
)
Less: Net income (loss) attributable to noncontrolling interests
2

 
2

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders
$
(737
)
 
$
(67
)
Comprehensive income (loss)
$
219

 
$
(925
)
Less: Comprehensive income (loss) attributable to noncontrolling interests
2

 
2

Comprehensive income (loss) attributable to Brighthouse Financial, Inc.
$
217

 
$
(927
)
Earnings per common share:
 
 
 
Basic
$
(6.31
)
 
$
(0.56
)
Diluted
$
(6.31
)
 
$
(0.56
)
See accompanying notes to the interim condensed consolidated financial statements.

3

Brighthouse Financial, Inc.
Interim Condensed Consolidated Statements of Equity
For the Three Months Ended March 31, 2019 and 2018 (Unaudited)
(In millions)
 
 
Preferred Stock
 
Common Stock
 
Additional Paid-in Capital
 
Retained Earnings (Deficit)
 
Treasury Stock at Cost
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Brighthouse Financial, Inc.’s Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
Balance at December 31, 2018
 
$
—

 
$
1

 
$
12,473

 
$
1,346

 
$
(118
)
 
$
716

 
$
14,418

 
$
65

 
$
14,483

Preferred stock issuance
 
—

 
 
 
412

 
 
 
 
 
 
 
412

 
 
 
412

Treasury stock acquired in connection with share repurchases
 
 
 

 

 

 
(52
)
 

 
(52
)
 

 
(52
)
Share-based compensation
 
 
 

 
4

 

 

 

 
4

 

 
4

Change in noncontrolling interests
 
 
 

 

 

 

 

 
—

 
(2
)
 
(2
)
Net income (loss)
 
 
 

 

 
(737
)
 

 

 
(737
)
 
2

 
(735
)
Other comprehensive income (loss), net of income tax
 
 
 


 


 


 


 
954

 
954

 


 
954

Balance at March 31, 2019
 
$
—

 
$
1

 
$
12,889

 
$
609

 
$
(170
)
 
$
1,670

 
$
14,999

 
$
65

 
$
15,064

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred Stock
 
Common Stock
 
Additional Paid-in Capital
 
Retained Earnings (Deficit)
 
Treasury Stock at Cost
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Brighthouse Financial, Inc.’s Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
Balance at December 31, 2017
 
$
—

 
$
1

 
$
12,432

 
$
406

 
$
—

 
$
1,676

 
$
14,515

 
$
65

 
$
14,580

Cumulative effect of change in accounting principle and other, net of income tax
 
 
 
 
 
 
 
75

 
 
 
(79
)
 
(4
)
 
 
 
(4
)
Balance at January 1, 2018
 
—

 
1

 
12,432

 
481

 
—

 
1,597

 
14,511

 
65

 
14,576

Change in noncontrolling interests
 


 


 


 


 


 


 
—

 
(2
)
 
(2
)
Net income (loss)
 


 


 


 
(67
)
 


 


 
(67
)
 
2

 
(65
)
Other comprehensive income (loss), net of income tax
 


 


 


 


 


 
(860
)
 
(860
)
 


 
(860
)
Balance at March 31, 2018
 
$
—


$
1


$
12,432


$
414

 
$
—


$
737

 
$
13,584

 
$
65

 
$
13,649

See accompanying notes to the interim condensed consolidated financial statements.

4

Brighthouse Financial, Inc.
Interim Condensed Consolidated Statements of Cash Flows
For the Three Months Ended March 31, 2019 and 2018 (Unaudited)
(In millions)
 
Three Months Ended
 March 31,
 
2019
 
2018
Net cash provided by (used in) operating activities
$
376

 
$
291

Cash flows from investing activities
 
 
 
Sales, maturities and repayments of:
 
 
 
Fixed maturity securities
4,100

 
4,057

Equity securities
6

 
6

Mortgage loans
263

 
169

Real estate limited partnerships and limited liability companies
1

 
74

Other limited partnership interests
76

 
42

Purchases of:
 
 
 
Fixed maturity securities
(3,830
)
 
(3,804
)
Equity securities
—

 
(1
)
Mortgage loans
(1,076
)
 
(739
)
Real estate limited partnerships and limited liability companies
(4
)
 
(15
)
Other limited partnership interests
(106
)
 
(38
)
Cash received in connection with freestanding derivatives
316

 
712

Cash paid in connection with freestanding derivatives
(310
)
 
(1,414
)
Net change in policy loans
36

 
7

Net change in short-term investments
(799
)
 
19

Net change in other invested assets
55

 
22

Net cash provided by (used in) investing activities
(1,272
)
 
(903
)
Cash flows from financing activities
 
 
 
Policyholder account balances:
 
 
 
Deposits
1,858

 
1,516

Withdrawals
(911
)
 
(772
)
Net change in payables for collateral under securities loaned and other transactions
(1,067
)
 
75

Long-term debt issued
1,000

 
—

Long-term debt repaid
(600
)
 
(3
)
Preferred stock issued, net of issuance costs
412

 
—

Treasury stock acquired in connection with share repurchases
(52
)
 
—

Financing element on certain derivative instruments and other derivative related transactions, net
(11
)
 
(157
)
Other, net
(14
)
 
(16
)
Net cash provided by (used in) financing activities
615

 
643

Change in cash, cash equivalents and restricted cash
(281
)
 
31

Cash, cash equivalents and restricted cash, beginning of period
4,145

 
1,857

Cash, cash equivalents and restricted cash, end of period
$
3,864

 
$
1,888

Supplemental disclosures of cash flow information
 
 
 
Net cash paid (received) for:
 
 
 
Interest
$
12

 
$
8

Income tax
$
(1
)
 
$
—

See accompanying notes to the interim condensed consolidated financial statements.

5
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies
Business
“Brighthouse Financial” and the “Company” refer to Brighthouse Financial, Inc. and its subsidiaries (formerly, MetLife U.S. Retail Separation Business). Brighthouse Financial, Inc. (“BHF”) is a holding company formed to own the legal entities that historically operated a substantial portion of MetLife, Inc.’s (together with its subsidiaries and affiliates, “MetLife”) former Retail segment. BHF was incorporated in Delaware on August 1, 2016 in preparation for MetLife, Inc.’s separation of a substantial portion of its former Retail segment, as well as certain portions of its former Corporate Benefit Funding segment (the “Separation”), which was completed on August 4, 2017.
In connection with the Separation, 80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock and MetLife, Inc. retained the remaining 19.2%. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture.
Brighthouse Financial is one of the largest providers of annuity and life insurance products in the United States through multiple independent distribution channels and marketing arrangements with a diverse network of distribution partners. The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other.
Basis of Presentation
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.
Consolidation
The accompanying interim condensed consolidated financial statements include the accounts of Brighthouse Financial, as well as partnerships and limited liability companies (“LLCs”) in which the Company has control. Intercompany accounts and transactions have been eliminated.
The Company uses the equity method of accounting for investments in limited partnerships and LLCs when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. When the Company has virtually no influence over the investee’s operations, the investment is carried at fair value.
Reclassifications
Certain amounts in the prior year periods’ interim condensed consolidated financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Consolidated Financial Statements.
The accompanying interim condensed consolidated financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 consolidated balance sheet data was derived from audited consolidated financial statements included in Brighthouse Financial, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated and combined financial statements of the Company included in the 2018 Annual Report.

6
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Adoption of New Accounting Pronouncements
Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during the first quarter of 2019 which had a material impact on the Company’s financial statements.
ASUs issued but not yet adopted as of March 31, 2019 are summarized in the table below.
Standard
Description
Effective Date
Impact on Financial Statements
ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
The amendments to Topic 350 require the capitalization of certain implementation costs incurred in a cloud computing arrangement that is a service contract. The requirements align with the existing requirements to capitalize implementation costs incurred to develop or obtain internal-use software.
January 1, 2020 using the prospective method or retrospective method (with early adoption permitted)
The Company is currently evaluating the impact of this guidance on its financial statements.
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts
The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs, and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances.
January 1, 2021 using a modified retrospective method for the new market risk benefit guidance and prospective methods for the increased frequency of updating assumptions, the new discount rate requirements and deferred policy acquisition costs (“DAC”) amortization changes. Early adoption is permitted.
The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.
January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)
The Company is currently evaluating the impact of this guidance on its financial statements, with the most significant impact expected to be earlier recognition of credit losses on mortgage loan investments.

7
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)


2. Segment Information
The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other.
Annuities
The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.
Life
The Life segment consists of insurance products and services, including term, universal, whole and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.
Run-off
The Run-off segment consists of products no longer actively sold and which are separately managed, including structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and universal life with secondary guarantees.
Corporate & Other
Corporate & Other contains the excess capital not allocated to the segments and interest expense related to the majority of the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts, long-term care and workers compensation business reinsured through 100% quota share reinsurance agreements, and term life insurance sold direct to consumers, which is no longer being offered for new sales.
Financial Measures and Segment Accounting Policies
Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by the investor community. Adjusted earnings should not be viewed as a substitute for net income (loss) available to BHF’s common shareholders and excludes net income (loss) attributable to noncontrolling interests.
Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends.
The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:
•
Net investment gains (losses);
•
Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and
•
Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).
The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:
•
Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);
•
Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and
•
Amortization of DAC and value of business acquired (“VOBA”) related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.
The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate.

8
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
2. Segment Information (continued)

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months ended March 31, 2019 and 2018 and at March 31, 2019 and December 31, 2018. The segment accounting policies are the same as those used to prepare the Company’s condensed consolidated financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.
Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital. Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets.
 
 
Operating Results
Three Months Ended March 31, 2019
 
Annuities
 
Life
 
Run-off
 
Corporate & Other
 
Total
 
 
(In millions)
Pre-tax adjusted earnings
 
$
361

 
$
31

 
$
(46
)
 
$
(72
)
 
$
274

Provision for income tax expense (benefit)
 
66

 
6

 
(10
)
 
(22
)
 
40

Post-tax adjusted earnings
 
295

 
25

 
(36
)
 
(50
)
 
234

Less: Net income (loss) attributable to noncontrolling interests
 
—

 
—

 
—

 
2

 
2

Adjusted earnings
 
$
295

 
$
25

 
$
(36
)
 
$
(52
)
 
232

Adjustments for:
 
 
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
 
 
(11
)
Net derivative gains (losses)
 
 
 
 
 
 
 
 
 
(1,303
)
Other adjustments to net income
 
 
 
 
 
 
 
 
 
87

Provision for income tax (expense) benefit
 
 
 
 
 
 
 
 
 
258

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders
 
 
 
 
 
 
 
 
 
$
(737
)
 
 
 
 
 
 
 
 
 
 
 
Interest revenue
 
$
421

 
$
97

 
$
276

 
$
17

 
 
Interest expense
 
$
—

 
$
—

 
$
—

 
$
47

 
 

9
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
2. Segment Information (continued)

 
 
Operating Results
Three Months Ended March 31, 2018
 
Annuities
 
Life
 
Run-off
 
Corporate & Other
 
Total
 
 
(In millions)
Pre-tax adjusted earnings
 
$
272

 
$
81

 
$
63

 
$
(86
)
 
$
330

Provision for income tax expense (benefit)
 
46

 
15

 
13

 
(29
)
 
45

Post-tax adjusted earnings
 
226

 
66

 
50

 
(57
)
 
285

Less: Net income (loss) attributable to noncontrolling interests
 
—

 
—

 
—

 
2

 
2

Adjusted earnings
 
$
226

 
$
66

 
$
50

 
$
(59
)
 
283

Adjustments for:
 
 
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
 
 
(4
)
Net derivative gains (losses)
 
 
 
 
 
 
 
 
 
(334
)
Other adjustments to net income
 
 
 
 
 
 
 
 
 
(105
)
Provision for income tax (expense) benefit
 
 
 
 
 
 
 
 
 
93

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders
 
 
 
 
 
 
 
 
 
$
(67
)
 
 
 
 
 
 
 
 
 
 
 
Interest revenue
 
$
363

 
$
108

 
$
343

 
$
11

 
 
Interest expense
 
$
—

 
$
—

 
$
—

 
$
37

 
 
The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Annuities
 
$
1,117

 
$
1,147

Life
 
303

 
369

Run-off
 
476

 
548

Corporate & Other
 
43

 
34

Adjustments
 
(1,248
)
 
(283
)
Total
 
$
691

 
$
1,815

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

 
March 31, 2019

December 31, 2018

 
(In millions)
Annuities
 
$
149,900

 
$
141,489

Life
 
20,546

 
20,449

Run-off
 
33,218

 
32,393

Corporate & Other
 
12,766

 
11,963

Total
 
$
216,430


$
206,294


10
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)

3. Insurance
Guarantees
As discussed in Notes 1 and 3 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report, the Company issues variable annuity contracts with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”), the non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”) and certain portions of GMIBs that do not require the policyholder to annuitize are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 5.
The Company also has universal and variable life insurance contracts with secondary guarantees.
Information regarding the Company’s guarantee exposure was as follows at:
 
March 31, 2019
 
December 31, 2018
 
 
In the
Event of Death
 
At
Annuitization
 
In the
Event of Death
 
At
Annuitization
 
 
(Dollars in millions)
 
Annuity Contracts (1), (2)
 
 
 
 
 
 
 
 
Variable Annuity Guarantees
 
 
 
 
 
 
 
 
Total account value (3)
$
103,148

 
$
59,507

 
$
96,865

 
$
55,967

 
Separate account value
$
98,148

 
$
58,291

 
$
91,837

 
$
54,731

 
Net amount at risk
$
7,643

(4)
$
3,301

(5)
$
11,073

(4)
$
4,128

(5)
Average attained age of contract holders
68 years

 
68 years

 
68 years

 
68 years

 
 
March 31, 2019
 
December 31, 2018
 
Secondary Guarantees
 
(Dollars in millions)
Universal Life Contracts
 
 
 
Total account value (3)
$
6,056

 
$
6,099

Net amount at risk (6)
$
72,642

 
$
73,131

Average attained age of policyholders
65 years

 
65 years

 
 
 
 
Variable Life Contracts
 
 
 
Total account value (3)
$
3,343

 
$
3,230

Net amount at risk (6)
$
22,522

 
$
23,004

Average attained age of policyholders
50 years

 
50 years

__________________
(1)
The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.
(2)
Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk presented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report for a discussion of guaranteed minimum benefits which have been reinsured.
(3)
Includes the contract holder’s investments in the general account and separate account, if applicable.
(4)
Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

11
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
3. Insurance (continued)

(5)
Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.
(6)
Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.
4. Investments
See Note 1 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report for a description of the Company’s accounting policies for investments and Note 6 for information about the fair value hierarchy for investments and the related valuation methodologies.
Fixed Maturity Securities Available-for-sale (“AFS”)
Fixed Maturity Securities AFS by Sector
The following table presents the fixed maturity securities AFS by sector at:
 
March 31, 2019
 
December 31, 2018
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair
Value
 
Gains
 
Temporary
Losses
 
OTTI
Losses (1)
 
Gains
 
Temporary
Losses
 
OTTI
Losses (1)
 
 
(In millions)
Fixed maturity securities: (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
$
24,716

 
$
1,373

 
$
233

 
$
—

 
$
25,856

 
$
24,312

 
$
830

 
$
669

 
$
—

 
$
24,473

U.S. government and agency
6,640

 
1,477

 
29

 
—

 
8,088

 
7,944

 
1,263

 
112

 
—

 
9,095

RMBS
8,648

 
297

 
65

 
(3
)
 
8,883

 
8,428

 
246

 
129

 
(2
)
 
8,547

Foreign corporate
8,908

 
322

 
157

 


 
9,073

 
8,183

 
159

 
316

 
—

 
8,026

CMBS
5,330

 
130

 
33

 
—

 
5,427

 
5,292

 
43

 
88

 
(1
)
 
5,248

State and political subdivision
3,289


525


3





3,811


3,200


412


15


—


3,597

ABS
2,075

 
15

 
12

 
—

 
2,078

 
2,135

 
13

 
22

 
—

 
2,126

Foreign government
1,495

 
146

 
10

 
—

 
1,631

 
1,426

 
102

 
32

 
—

 
1,496

Total fixed maturity securities
$
61,101


$
4,285


$
542


$
(3
)

$
64,847


$
60,920


$
3,068


$
1,383


$
(3
)

$
62,608

__________________
(1)
Noncredit OTTI losses included in accumulated other comprehensive income (loss) (“AOCI”) in an unrealized gain position are due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities.
(2)
Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).
The Company held non-income producing fixed maturity securities with an estimated fair value of $28 million and less than $1 million with unrealized gains (losses) of ($5) million and less than $1 million at March 31, 2019 and December 31, 2018, respectively.

12
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Maturities of Fixed Maturity Securities
The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at March 31, 2019:
 
Due in One
Year or Less
 
Due After One
Year Through
Five Years
 
Due After Five
Years Through Ten Years
 
Due After Ten
Years
 
Structured
Securities
 
Total Fixed
Maturity
Securities
 
(In millions)
Amortized cost
$
1,577

 
$
7,692

 
$
12,155

 
$
23,624

 
$
16,053

 
$
61,101

Estimated fair value
$
1,584

 
$
7,818

 
$
12,411

 
$
26,646

 
$
16,388

 
$
64,847

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.
Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector
The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:
 
March 31, 2019
 
December 31, 2018
 
Less than 12 Months
 
Equal to or Greater
 than 12 Months
 
Less than 12 Months
 
Equal to or Greater
than 12 Months
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
(Dollars in millions)
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
$
2,664

 
$
85

 
$
3,774

 
$
148

 
$
10,584

 
$
470

 
$
2,328

 
$
199

U.S. government and agency
243

 
1

 
852

 
28

 
412

 
8

 
1,543

 
104

RMBS
796

 
5

 
2,665

 
57

 
1,627

 
26

 
2,611

 
101

Foreign corporate
1,610

 
67

 
1,164

 
90

 
3,982

 
203

 
774

 
113

CMBS
323

 
16

 
1,043

 
17

 
2,317

 
53

 
803

 
34

State and political subdivision
31

 
1

 
129

 
2

 
346

 
7

 
158

 
8

ABS
874

 
10

 
161

 
2

 
1,422

 
21

 
70

 
1

Foreign government
275

 
9

 
30

 
1

 
521

 
26

 
132

 
6

Total fixed maturity securities
$
6,816


$
194


$
9,818


$
345


$
21,211


$
814


$
8,419


$
566

Total number of securities in an unrealized loss position
1,188

 
 
 
1,252

 
 
 
3,027

 
 
 
1,028

 
 

13
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities
Evaluation and Measurement Methodologies
Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.
For securities in an unrealized loss position, an OTTI is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in other comprehensive income (“OCI”).
Current Period Evaluation
Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at March 31, 2019.
Gross unrealized losses on fixed maturity securities decreased $841 million during the three months ended March 31, 2019 to $539 million. The decrease in gross unrealized losses for the three months ended March 31, 2019 was primarily attributable to decreasing longer-term interest rates and narrowing credit spreads.
At March 31, 2019, $17 million of the total $539 million of gross unrealized losses were from eight fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater.

14
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Mortgage Loans
Mortgage Loans by Portfolio Segment
Mortgage loans are summarized as follows at:
 
March 31, 2019
 
December 31, 2018
 
Carrying
Value
 
% of
Total
 
Carrying
Value
 
% of
Total
 
(Dollars in millions)
Mortgage loans:
 
 
 
 
 
 
 
Commercial
$
8,748

 
60.3
 %
 
$
8,529

 
62.3
 %
Agricultural
3,155

 
21.8

 
2,946

 
21.5

Residential
2,661

 
18.3

 
2,276

 
16.6

Subtotal (1)
14,564

 
100.4

 
13,751

 
100.4

Valuation allowances (2)
(60
)
 
(0.4
)
 
(57
)
 
(0.4
)
Total mortgage loans, net
$
14,504

 
100.0
 %
 
$
13,694

 
100.0
 %
__________________
(1)
Purchases of mortgage loans from third parties were $477 million and $86 million for the three months ended March 31, 2019 and 2018, respectively, and were primarily comprised of residential mortgage loans.
(2)
The valuation allowances were primarily from collective evaluation (non-specific loan related).
Information on commercial, agricultural and residential mortgage loans is presented in the tables below.
Valuation Allowance Methodology
Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

15
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Credit Quality of Commercial Mortgage Loans
The credit quality of commercial mortgage loans was as follows at:
 
Recorded Investment
 
 
 
 
 
Debt Service Coverage Ratios
 
 
 
% of
Total
 
Estimated
Fair
Value
 
% of
Total
 
> 1.20x
 
1.00x - 1.20x
 
< 1.00x
 
Total
 
 
(Dollars in millions)
March 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
Loan-to-value ratios:
 
 
 
 
 
 
 
 
 
 
 
 
 
Less than 65%
$
7,676

 
$
89

 
$
34

 
$
7,799

 
89.2
%
 
$
7,987

 
89.2
%
65% to 75%
800

 
—

 
—

 
800

 
9.1

 
819

 
9.1

76% to 80%
140

 
—

 
9

 
149

 
1.7

 
146

 
1.7

Total
$
8,616


$
89


$
43


$
8,748

 
100.0
%
 
$
8,952

 
100.0
%
December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
Loan-to-value ratios:
 
 
 
 
 
 
 
 
 
 
 
 
 
Less than 65%
$
7,470

 
$
89

 
$
34

 
$
7,593

 
89.0
%
 
$
7,668

 
89.0
%
65% to 75%
762

 
—

 
24

 
786

 
9.2

 
798

 
9.3

76% to 80%
141

 
—

 
9

 
150

 
1.8

 
145

 
1.7

Total
$
8,373


$
89


$
67


$
8,529

 
100.0
%
 
$
8,611

 
100.0
%
Credit Quality of Agricultural Mortgage Loans
The credit quality of agricultural mortgage loans was as follows at: 
 
March 31, 2019
 
December 31, 2018
 
Recorded
Investment
 
% of
Total
 
Recorded
Investment 
 
% of
Total
 
(Dollars in millions)
Loan-to-value ratios:
 
 
 
 
 
 
 
Less than 65%
$
2,827

 
89.6
%
 
$
2,623

 
89.0
%
65% to 75%
327

 
10.3

 
322

 
10.9

76% to 80%
1

 
0.1

 
1

 
0.1

Total
$
3,155

 
100.0
%
 
$
2,946

 
100.0
%
The estimated fair value of agricultural mortgage loans was $3.2 billion and $2.9 billion at March 31, 2019 and December 31, 2018, respectively.
Credit Quality of Residential Mortgage Loans
The credit quality of residential mortgage loans was as follows at:
 
March 31, 2019
 
December 31, 2018
 
Recorded Investment
 
% of
Total
 
Recorded Investment
 
% of
Total
 
(Dollars in millions)
Performance indicators:
 
 
 
 
 
 
 
Performing
$
2,622

 
98.5
%
 
$
2,240

 
98.4
%
Nonperforming
39

 
1.5

 
36

 
1.6

Total
$
2,661

 
100.0
%
 
$
2,276

 
100.0
%

16
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

The estimated fair value of residential mortgage loans was $2.7 billion and $2.3 billion at March 31, 2019 and December 31, 2018, respectively.
Past Due, Nonaccrual and Modified Mortgage Loans
The Company has a high quality, well performing mortgage loan portfolio, with over 99% of all mortgage loans classified as performing at both March 31, 2019 and December 31, 2018. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company had no commercial mortgage loans past due and no commercial mortgage loans in nonaccrual status at either March 31, 2019 or December 31, 2018. Agricultural mortgage loans past due totaled $7 million and less than $1 million at March 31, 2019 and December 31, 2018, respectively. The Company had no agricultural mortgage loans in nonaccrual status at either March 31, 2019 or December 31, 2018. Residential mortgage loans past due and in nonaccrual status totaled $39 million and $36 million at March 31, 2019 and December 31, 2018, respectively. During the three months ended March 31, 2019, the Company did not have mortgage loans modified in a troubled debt restructuring. The Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring during the three months ended March 31, 2018.
Other Invested Assets
Freestanding derivatives with positive estimated fair values comprise over 90% of other invested assets. See Note 5 for information about freestanding derivatives with positive estimated fair values. Other invested assets also includes tax credit and renewable energy partnerships, leveraged leases and Federal Home Loan Bank stock.
Cash Equivalents
The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $1.1 billion and $3.1 billion at March 31, 2019 and December 31, 2018, respectively.
Net Unrealized Investment Gains (Losses)
Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, VOBA, deferred sales inducements (“DSI”) and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI.
The components of net unrealized investment gains (losses), included in AOCI, were as follows:
 
March 31, 2019
 
December 31, 2018
 
(In millions)
Fixed maturity securities
$
3,749

 
$
1,691

Derivatives
204

 
264

Other
(12
)
 
(13
)
Subtotal
3,941

 
1,942

Amounts allocated from:
 
 
 
Future policy benefits
(1,564
)
 
(886
)
DAC, VOBA and DSI
(200
)
 
(90
)
Subtotal
(1,764
)
 
(976
)
Deferred income tax benefit (expense)
(457
)
 
(203
)
Net unrealized investment gains (losses)
$
1,720

 
$
763


17
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

The changes in net unrealized investment gains (losses) were as follows:
 
Three Months Ended
 March 31, 2019
 
(In millions)
Balance, December 31, 2018
$
763

Unrealized investment gains (losses) during the period
1,999

Unrealized investment gains (losses) relating to:
 
Future policy benefits
(678
)
DAC, VOBA and DSI
(110
)
Deferred income tax benefit (expense)
(254
)
Balance, March 31, 2019
$
1,720

Change in net unrealized investment gains (losses)
$
957

Concentrations of Credit Risk
There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both March 31, 2019 and December 31, 2018.
Securities Lending
Elements of the securities lending program are presented below at:
 
March 31, 2019
 
December 31, 2018
 
(In millions)
Securities on loan: (1)
 
 
 
Amortized cost
$
2,568

 
$
3,056

Estimated fair value
$
3,360

 
$
3,628

Cash collateral received from counterparties (2)
$
3,407

 
$
3,646

Security collateral received from counterparties (3)
$
36

 
$
55

Reinvestment portfolio — estimated fair value
$
3,426

 
$
3,658

__________________
(1)
Included within fixed maturity securities.
(2)
Included within payables for collateral under securities loaned and other transactions.
(3)
Security collateral received from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.
The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:
 
March 31, 2019
 
December 31, 2018
 
Remaining Tenor of Securities Lending Agreements
 
 
 
Remaining Tenor of Securities Lending Agreements
 
 
 
Open (1)
 
1 Month or Less
 
1 to 6 Months
 
Total
 
Open (1)
 
1 Month or Less
 
1 to 6 Months
 
Total
 
(In millions)
U.S. government and agency
$
1,567

 
$
940

 
$
900

 
$
3,407

 
$
1,474

 
$
1,823

 
$
349

 
$
3,646

__________________
(1)
The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

18
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized under normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at March 31, 2019 was $1.5 billion, all of which were U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement.
The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including agency RMBS, U.S. and foreign corporate securities, ABS, non-agency RMBS and U.S. government and agency securities) with 53% invested in agency RMBS, cash and cash equivalents, U.S. government and agency securities, and short-term investments at March 31, 2019. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company.
Invested Assets on Deposit, Held in Trust and Pledged as Collateral
Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value at:
 
March 31, 2019
 
December 31, 2018
 
(In millions)
Invested assets on deposit (regulatory deposits) (1)
$
8,592

 
$
8,176

Invested assets held in trust (reinsurance agreements) (2)
3,788

 
3,455

Invested assets pledged as collateral (3)
3,501

 
3,341

Total invested assets on deposit, held in trust and pledged as collateral
$
15,881


$
14,972

__________________
(1)
The Company has assets, primarily fixed maturity securities, on deposit with governmental authorities relating to certain policyholder liabilities, of which $101 million and $55 million of the assets on deposit balance represents restricted cash at March 31, 2019 and December 31, 2018, respectively.
(2)
The Company has assets, primarily fixed maturity securities, held in trust relating to certain reinsurance transactions. $58 million and $87 million of the assets held in trust balance represents restricted cash at March 31, 2019 and December 31, 2018, respectively.
(3)
The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 3 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report) and derivative transactions (see Note 5).
See “— Securities Lending” for information regarding securities on loan.
Variable Interest Entities
The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.
There were no material VIEs for which the Company has concluded that it is the primary beneficiary at March 31, 2019 or December 31, 2018.
The Company’s investments in unconsolidated VIEs are described below.

19
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Fixed Maturity Securities
The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.
Limited Partnerships and LLCs
The Company holds investments in certain limited partnerships and LLCs which are VIEs. These ventures include real estate limited partnerships/LLCs, private equity funds, hedge funds, and to a lesser extent tax credit and renewable energy partnerships. The Company is not considered the primary beneficiary, or consolidator, when its involvement takes the form of a limited partner interest and is restricted to a role of a passive investor, as a limited partner’s interest does not provide the Company with any substantive kick-out or participating rights, nor does it provide the Company with the power to direct the activities of the fund. The Company’s maximum exposure to loss on these investments is limited to: (i) the amount invested in debt or equity of the VIE and (ii) commitments to the VIE, as described in Note 11.
 
March 31, 2019
 
December 31, 2018
 
Carrying
Amount
 
Maximum
Exposure
to Loss
 
Carrying
Amount
 
Maximum
Exposure
to Loss
 
(In millions)
Fixed maturity securities
$
13,317

 
$
13,003

 
$
13,099

 
$
13,099

Limited partnerships and LLCs
1,722

 
2,887

 
1,756

 
3,145

Total
$
15,039

 
$
15,890

 
$
14,855

 
$
16,244

Net Investment Income
The components of net investment income were as follows:

Three Months Ended
 March 31,

2019

2018

(In millions)
Investment income:



Fixed maturity securities
$
653

 
$
628

Equity securities
3

 
2

Mortgage loans
159

 
120

Policy loans
16

 
16

Real estate limited partnerships and limited liability companies
8

 
14

Other limited partnership interests
—

 
65

Cash, cash equivalents and short-term investments
14

 
6

Other
13

 
9

Subtotal
866


860

Less: Investment expenses
55

 
43

Net investment income
$
811


$
817


20
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
4. Investments (continued)

Net Investment Gains (Losses)
Components of Net Investment Gains (Losses)
The components of net investment gains (losses) were as follows:

Three Months Ended
 March 31,
 
2019

2018

(In millions)
Fixed maturity securities 
$
(15
)
 
$
(39
)
Equity securities
10

 
(1
)
Mortgage loans
(4
)
 
(4
)
Real estate limited partnerships and limited liability companies
(1
)
 
42

Other limited partnership interests
(2
)
 
—

Other
1

 
(2
)
Total net investment gains (losses)
$
(11
)
 
$
(4
)
Sales or Disposals of Fixed Maturity Securities
Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.
 
Three Months Ended
 March 31,
 
2019
 
2018
 
(In millions)
Proceeds
$
3,279

 
$
2,861

Gross investment gains
$
67

 
$
3

Gross investment losses
(82
)
 
(42
)
Net investment gains (losses)
$
(15
)
 
$
(39
)
5. Derivatives
Accounting for Derivatives
Freestanding Derivatives
Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.
If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except for economic hedges of limited partnerships and LLCs which are presented in net investment income.
Hedge Accounting
The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

21
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.
The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.
When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.
In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).
Embedded Derivatives
The Company sells variable and index-linked annuities and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated and measured at fair value, separately from the host contract. The Company bifurcates embedded derivatives when a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument, the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and the underlying contract is not already measured at estimated fair value with changes recorded in earnings.
See “— Variable Annuity Guarantees”, “— Index-Linked Annuities” and “— Reinsurance” in Note 1 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.
Derivative Strategies
The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.
Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash markets.
Interest Rate Derivatives
The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, interest rate total return swaps, caps, floors, swaptions and futures.

22
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and nonqualifying hedging relationships.
Interest rate total return swaps are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and a floating rate, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate total return swaps are used by the Company to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate total return swaps in nonqualifying hedging relationships.
The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in nonqualifying hedging relationships.
In exchange-traded interest rate Treasury futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate Treasury futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury curve performance, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in nonqualifying hedging relationships.
Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in nonqualifying hedging relationships. Swaptions are included in interest rate options.
Foreign Currency Exchange Rate Derivatives
The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.
To a lesser extent, the Company uses foreign currency forwards in nonqualifying hedging relationships.
Credit Derivatives
The Company enters into written credit default swaps to create synthetic credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. government and agency securities or other fixed maturity securities.


23
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

To a lesser extent, the Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in nonqualifying hedging relationships.
Equity Derivatives
The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and equity total return swaps.
Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in nonqualifying hedging relationships.
Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in nonqualifying hedging relationships.
In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts and to pledge initial margin based on futures exchange requirements. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in nonqualifying hedging relationships.
In an equity total return swap, the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and a floating rate, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses equity total return swaps to hedge its equity market guarantees in certain of its insurance products. Equity total return swaps can be used as hedges or to create synthetic investments. The Company utilizes equity total return swaps in nonqualifying hedging relationships.

24
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

Primary Risks Managed by Derivatives
The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
 
 
 
March 31, 2019
 
December 31, 2018
 
Primary Underlying Risk Exposure
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
 
(In millions)
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps
Foreign currency exchange rate
 
$
2,563

 
$
179

 
$
37

 
$
2,524

 
$
211

 
$
30

Total qualifying hedges
 
 
2,563

 
179

 
37

 
2,524

 
211

 
30

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
Interest rate
 
10,397

 
651

 
457

 
10,747

 
528

 
558

Interest rate caps
Interest rate
 
3,350

 
10

 
—

 
3,350

 
21

 
—

Interest rate futures
Interest rate
 
54

 
—

 
—

 
54

 
—

 
—

Interest rate options
Interest rate
 
23,668

 
255

 
73

 
17,168

 
168

 
61

Foreign currency swaps
Foreign currency exchange rate
 
1,128

 
91

 
17

 
1,409

 
101

 
18

Foreign currency forwards
Foreign currency exchange rate
 
124

 
—

 
—

 
125

 
—

 
—

Credit default swaps — purchased
Credit
 
67

 
—

 
—

 
98

 
3

 
—

Credit default swaps — written
Credit
 
1,855

 
25

 
—

 
1,820

 
14

 
3

Equity futures
Equity market
 
—

 
—

 
—

 
169

 
—

 
—

Equity index options
Equity market
 
42,813

 
771

 
1,541

 
45,815

 
1,372

 
1,207

Equity variance swaps
Equity market
 
5,574

 
91

 
242

 
5,574

 
80

 
232

Equity total return swaps
Equity market
 
4,550

 
—

 
219

 
3,920

 
280

 
3

Total non-designated or nonqualifying derivatives
 
93,580

 
1,894

 
2,549

 
90,249

 
2,567

 
2,082

Total
 
 
$
96,143

 
$
2,073

 
$
2,586

 
$
92,773

 
$
2,778

 
$
2,112

Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both March 31, 2019 and December 31, 2018. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to create synthetic credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these nonqualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.

25
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

The following tables present the amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):
 
Net Derivative Gains (Losses) Recognized for Derivatives (1), (6)
 
Net Derivative Gains (Losses) Recognized for Hedged
Items (2), (6)
 
Net Investment Income (1), (3), (7)
 
Policyholder Benefits and Claims (4)
 
Amount of Gains (Losses) deferred in AOCI
 
(In millions)
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
Cash flow hedges (5):
 
 
 
 
 
 
 
 
 
Interest rate derivatives
$
22

 
$
—

 
$
1

 
$
—

 
$
—

Foreign currency exchange rate derivatives
3

 
—

 
8

 
—

 
(34
)
Total cash flow hedges
25

 
—

 
9

 
—

 
(34
)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
Interest rate derivatives
332

 
—

 
—

 
—

 
—

Foreign currency exchange rate derivatives
(8
)
 
—

 
—

 
—

 
—

Credit derivatives
18

 
—

 
—

 
—

 
—

Equity derivatives
(1,446
)
 
—

 
—

 
—

 
—

Embedded derivatives
(224
)
 
—

 
—

 
—

 
—

Total non-qualifying hedges
(1,328
)
 
—

 
—

 
—

 
—

Total
$
(1,303
)
 
$
—

 
$
9

 
$
—

 
$
(34
)
Three Months Ended March 31, 2018
 
 
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
Fair value hedges (5):
 
 
 
 
 
 
 
 
 
Interest rate derivatives
$
(8
)
 
$
7

 
$
1

 
$
—

 
$
—

Total fair value hedges
(8
)
 
7

 
1

 
—

 
—

Cash flow hedges (5):
 
 
 
 
 
 
 
 
 
Interest rate derivatives
7

 
—

 
1

 
—

 
(2
)
Foreign currency exchange rate derivatives
—

 
—

 
4

 
—

 
(74
)
Total cash flow hedges
7

 
—

 
5

 
—

 
(76
)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
Interest rate derivatives
(773
)
 
—

 
—

 
—

 
—

Foreign currency exchange rate derivatives
(37
)
 
2

 
—

 
—

 
—

Credit derivatives
(4
)
 
—

 
—

 
—

 
—

Equity derivatives
(34
)
 
—

 
—

 
—

 
—

Embedded derivatives
506

 
—

 
—

 
(1
)
 
—

Total non-qualifying hedges
(342
)
 
2

 
—

 
(1
)
 
—

Total
$
(343
)
 
$
9

 
$
6

 
$
(1
)
 
$
(76
)
______________
(1)
Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.
(2)
Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.
(3)
Includes changes in estimated fair value related to economic hedges of limited partnerships and LLCs.
(4)
Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.
(5)
All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

26
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

(6)
Total net derivative gains (losses) were ($1.3) billion and ($334) million for the three months ended March 31, 2019 and 2018, respectively.
(7)
Total net investment income was $811 million and $817 million for the three months ended March 31, 2019 and 2018, respectively.
At March 31, 2019 and December 31, 2018, the balance in AOCI associated with cash flow hedges was $204 million and $264 million, respectively.
Credit Derivatives
In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the nonqualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current estimated fair value of the credit default swaps.
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at: 
 
 
March 31, 2019
 
December 31, 2018
Rating Agency Designation of Referenced
Credit Obligations (1)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of
Future
Payments under
Credit Default
Swaps
 
Weighted
Average
Years to
Maturity (2)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of
Future
Payments under
Credit Default
Swaps
 
Weighted
Average
Years to
Maturity (2)
 
 
(Dollars in millions)
Aaa/Aa/A
 
$
18

 
$
1,376

 
3.3
 
$
8

 
$
689

 
2.0
Baa
 
7

 
479

 
4.9
 
3

 
1,131

 
5.0
Total
 
$
25

 
$
1,855

 
3.8
 
$
11

 
$
1,820

 
3.9
__________________
(1)
Includes both single name credit default swaps that may be referenced to the credit of corporations, foreign governments or state and political subdivisions and credit default swaps referencing indices. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), Standard & Poor’s Global Ratings (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
(2)
The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
Counterparty Credit Risk
The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.
The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

27
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.
See Note 6 for a description of the impact of credit risk on the valuation of derivatives.
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: 
 
 
March 31, 2019
 
December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
(In millions)
Gross estimated fair value of derivatives:
 
 
 
 
 
 
 
 
OTC-bilateral (1)
 
$
2,095

 
$
2,563

 
$
2,813

 
$
2,102

OTC-cleared and Exchange-traded (1), (6)
 
17

 
—

 
20

 
2

Total gross estimated fair value of derivatives (1)
 
2,112

 
2,563

 
2,833

 
2,104

Estimated fair value of derivatives presented on the consolidated balance sheets (1), (6)
 
2,112

 
2,563

 
2,833

 
2,104

Gross amounts not offset on the consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross estimated fair value of derivatives: (2)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(1,398
)
 
(1,398
)
 
(1,669
)
 
(1,669
)
OTC-cleared and Exchange-traded
 
—

 
—

 
(2
)
 
(2
)
Cash collateral: (3), (4)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(496
)
 
—

 
(1,047
)
 
—

OTC-cleared and Exchange-traded
 
(17
)
 
—

 
(15
)
 
—

Securities collateral: (5)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(179
)
 
(1,156
)
 
(86
)
 
(433
)
Net amount after application of master netting agreements and collateral
 
$
22

 
$
9

 
$
14

 
$
—

__________________
(1)
At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $39 million and $55 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($23) million and ($8) million, respectively.
(2)
Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)
Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.
(4)
The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $70 million and $349 million, respectively, and provided excess cash collateral of $15 million and $64 million, respectively, which is not included in the table above due to the foregoing limitation.

28
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

(5)
Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2019, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2019 and December 31, 2018, the Company received excess securities collateral with an estimated fair value of $96 million and $59 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2019 and December 31, 2018, the Company provided excess securities collateral with an estimated fair value of $288 million and $364 million, respectively, for its OTC-bilateral derivatives, and $99 million and $81 million, respectively, for its OTC-cleared derivatives, and $8 million and $14 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
(6)
Effective January 16, 2018, the London Clearing House (“LCH”) amended its rulebook, resulting in the characterization of variation margin transfers as settlement payments, as opposed to adjustments to collateral. These amendments impacted the accounting treatment of the Company’s centrally cleared derivatives, for which the LCH serves as the central clearing party.
The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. A small number of these arrangements also include credit-contingent provisions that include a threshold above which collateral must be posted. Such agreements provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of the Company and/or the counterparty. In addition, substantially all of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s financial strength or credit ratings were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The Company’s collateral agreements require both parties to be fully collateralized, as such, the Company would not be required to post additional collateral as a result of a downgrade in its financial strength rating. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.  
 
 
March 31, 2019
 
December 31, 2018
 
 
(In millions)
Estimated fair value of derivatives in a net liability position (1)
 
$
1,165

 
$
433

Estimated Fair Value of Collateral Provided:
 
 
 
 
Fixed maturity securities
 
$
1,444

 
$
797

__________________
(1)
After taking into consideration the existence of netting agreements.
Embedded Derivatives
The Company issues certain insurance contracts that contain embedded derivatives that are required to be separated from their host contracts and measured at fair value. These host contracts include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; index-linked annuities that are directly written or assumed through reinsurance; and ceded reinsurance of variable annuity GMIBs.

29
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
 
Balance Sheet Location
 
March 31, 2019
 
December 31, 2018
 
 
 
(In millions)
Embedded derivatives within asset host contracts:
 
 
 
 
Ceded guaranteed minimum income benefits
Premiums, reinsurance and other receivables
 
$
219

 
$
228

 
 
 
 
 
 
Embedded derivatives within liability host contracts:
 
 
 
 
Direct guaranteed minimum benefits
Policyholder account balances
 
$
1,260

 
$
1,642

Direct index-linked annuities
Policyholder account balances
 
1,249

 
488

Assumed index-linked annuities
Policyholder account balances
 
146

 
96

Embedded derivatives within liability host contracts
 
$
2,655

 
$
2,226

The following table presents changes in estimated fair value related to embedded derivatives:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Net derivative gains (losses) (1)
 
$
(224
)
 
$
506

Policyholder benefits and claims
 
$
—

 
$
(1
)
__________________
(1)
The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were ($163) million and ($15) million for the three months ended March 31, 2019 and 2018, respectively.


30
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)

6. Fair Value
Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, are presented below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.
 
March 31, 2019
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$
—

 
$
25,562

 
$
294

 
$
25,856

U.S. government and agency
2,075

 
6,013

 
—

 
8,088

RMBS
—

 
8,864

 
19

 
8,883

Foreign corporate
—

 
8,670

 
403

 
9,073

CMBS
—

 
5,299

 
128

 
5,427

State and political subdivision
—

 
3,737

 
74

 
3,811

ABS
—

 
1,997

 
81

 
2,078

Foreign government
—

 
1,631

 
—

 
1,631

Total fixed maturity securities
2,075

 
61,773

 
999

 
64,847

Equity securities
14

 
132

 
4

 
150

Short term investments
557

 
242

 
—

 
799

Derivative assets: (1)
 
 
 
 
 
 
 
Interest rate
—

 
916

 
—

 
916

Foreign currency exchange rate
—

 
264

 
6

 
270

Credit
—

 
18

 
7

 
25

Equity market
—

 
762

 
100

 
862

Total derivative assets
—

 
1,960

 
113

 
2,073

Embedded derivatives within asset host contracts (2)
—

 
—

 
219

 
219

Separate account assets
262

 
104,949

 
—

 
105,211

Total assets
$
2,908

 
$
169,056

 
$
1,335

 
$
173,299

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (1)
 
 
 
 
 
 
 
Interest rate
$
—

 
$
530

 
$
—

 
$
530

Foreign currency exchange rate
—

 
52

 
2

 
54

Credit
—

 
—

 
—

 
—

Equity market
—

 
1,755

 
247

 
2,002

Total derivative liabilities
—

 
2,337

 
249

 
2,586

Embedded derivatives within liability host contracts (2)
—

 
—

 
2,655

 
2,655

Total liabilities
$
—

 
$
2,337

 
$
2,904

 
$
5,241


31
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

 
December 31, 2018
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$
—

 
$
24,150

 
$
323

 
$
24,473

U.S. government and agency
2,722

 
6,373

 
—

 
9,095

RMBS
—

 
8,541

 
6

 
8,547

Foreign corporate
—

 
7,617

 
409

 
8,026

CMBS
—

 
5,120

 
128

 
5,248

State and political subdivision
—

 
3,523

 
74

 
3,597

ABS
—

 
2,087

 
39

 
2,126

Foreign government
—

 
1,496

 
—

 
1,496

Total fixed maturity securities
2,722

 
58,907

 
979

 
62,608

Equity securities
13

 
124

 
3

 
140

Derivative assets: (1)
 
 
 
 
 
 
 
Interest rate
—

 
717

 
—

 
717

Foreign currency exchange rate
—

 
301

 
11

 
312

Credit
—

 
10

 
7

 
17

Equity market
—

 
1,634

 
98

 
1,732

Total derivative assets
—

 
2,662

 
116

 
2,778

Embedded derivatives within asset host contracts (2)
—

 
—

 
228

 
228

Separate account assets
217

 
98,038

 
1

 
98,256

Total assets
$
2,952

 
$
159,731

 
$
1,327

 
$
164,010

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (1)
 
 
 
 
 
 
 
Interest rate
$
—

 
$
619

 
$
—

 
$
619

Foreign currency exchange rate
—

 
48

 
—

 
48

Credit
—

 
2

 
1

 
3

Equity market
—

 
1,205

 
237

 
1,442

Total derivative liabilities
—

 
1,874

 
238

 
2,112

Embedded derivatives within liability host contracts (2)
—

 
—

 
2,226

 
2,226

Total liabilities
$
—

 
$
1,874

 
$
2,464

 
$
4,338

__________________
(1)
Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
(2)
Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the consolidated balance sheets.

32
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

Valuation Controls and Procedures
The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards.
The fair value of financial assets and financial liabilities is based on quoted market prices, where available. The Company assesses whether prices received represent a reasonable estimate of fair value through controls designed to ensure valuations represent an exit price. Valuation service providers perform several controls, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.
Valuation service providers also apply a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, valuation service providers will use the last available price.
The Company reviews outputs of the valuation service providers’ controls and performs additional controls, including certain monthly controls, which include but are not limited to, performing balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the three months ended March 31, 2019.
Determination of Fair Value
Fixed Maturity Securities
The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.
U.S. corporate and foreign corporate securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.
U.S. government and agency, state and political subdivision and foreign government securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker dealer quotes, and comparable securities that are actively traded.

33
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

Structured Securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.
Equity Securities and Short-Term Investments
The fair value for actively traded equity securities and short-term investments are determined using quoted market prices and are classified as Level 1 assets. For financial instruments classified as Level 2 assets or liabilities, fair values are determined using a market approach and are valued based on a variety of observable inputs as described below.
Equity securities and short-term investments: Fair value is determined using third-party commercial pricing services, with the primary input being quoted prices in markets that are not active.
Derivatives
The fair values for exchange-traded derivatives are determined using the quoted market prices and are classified as Level 1 assets. For OTC-bilateral derivatives and OTC-cleared derivatives classified as Level 2 assets or liabilities, fair values are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.
The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.
Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.
The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.
Embedded Derivatives
Embedded derivatives principally include certain direct and ceded variable annuity guarantees, equity crediting rates within index-linked annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.
The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

34
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.
Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.
The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength.
Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.
The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Equity securities and short-term investments.” The estimated fair value of these embedded derivatives is included, along with the funds withheld liability, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses).
The Company issues and assumes through reinsurance index-linked annuities which allow the policyholder to participate in returns from equity indices. The crediting rates associated with these features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.
The estimated fair value of crediting rates associated with index-linked annuities is determined using a combination of an option pricing model and an option-budget approach. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.
Transfers Into or Out of Level 3:
Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

35
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
March 31, 2019
 
December 31, 2018
 
Impact of
Increase in Input
on Estimated
Fair Value
 
Valuation Techniques
 
Significant
Unobservable Inputs
 
Range
 
Range
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
Direct, assumed and ceded guaranteed minimum benefits
•
Option pricing techniques
 
•
Mortality rates
 
0.02%
 
11.31%
 
0.02%
 
11%
 
Decrease (1)
 
 
 
 
•
Lapse rates
 
0.25%
 
16%
 
0.25%
 
16%
 
Decrease (2)
 
 
 
 
•
Utilization rates
 
0%
 
25%
 
0%
 
25%
 
Increase (3)
 
 
 
 
•
Withdrawal rates
 
0.25%
 
10%
 
0.25%
 
10%
 
(4)
 
 
 
 
•
Long-term equity volatilities
 
16.50%
 
22%
 
16.50%
 
22%
 
Increase (5)
 
 
 
 
•
Nonperformance risk spread
 
1.31%
 
2.45%
 
1.91%
 
2.66%
 
Decrease (6)
___________________
(1)
Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.
(2)
Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.
(3)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.
(4)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(5)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(6)
Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

36
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
Corporate (1)
 
Structured Securities
 
State and
Political
Subdivision
 
Foreign
Government
 
Equity
Securities
 
Short Term
Investments
 
Net
Derivatives (2)
 
Net Embedded
Derivatives (3)
 
Separate
Account Assets (4)
 
 
(In millions)
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
732

 
$
173

 
$
74

 
$
—

 
$
3

 
$
—

 
$
(122
)
 
$
(1,998
)
 
$
1

Total realized/unrealized gains (losses) included in net income (loss) (5) (6)
 
—

 
(1
)
 
—

 
—

 
—

 
—

 
(9
)
 
(224
)
 
—

Total realized/unrealized gains (losses)
included in AOCI
 
8

 
2

 
—

 
—

 
—

 
—

 
(3
)
 
—

 
—

Purchases (7)
 
16

 
29

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Sales (7)
 
(2
)
 
(13
)
 
—

 
—

 
—

 
—

 
—

 
—

 
(1
)
Issuances (7)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Settlements (7)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(214
)
 
—

Transfers into Level 3 (8)
 
35

 
45

 
—

 
—

 
1

 
—

 
—

 
—

 
—

Transfers out of Level 3 (8)
 
(92
)
 
(7
)
 
—

 
—

 
—

 
—

 
(2
)
 
—

 
—

Balance, end of period
 
$
697

 
$
228

 
$
74

 
$
—

 
$
4

 
$
—

 
$
(136
)
 
$
(2,436
)
 
$
—

Three Months Ended March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
1,997

 
$
1,230

 
$
—

 
$
5

 
$
124

 
$
14

 
$
(279
)
 
$
(1,660
)
 
$
5

Total realized/unrealized gains (losses) included in net income (loss) (5) (6)
 
3

 
6

 
—

 
—

 
(1
)
 
—

 
5

 
505

 
—

Total realized/unrealized gains (losses)
included in AOCI
 
(8
)
 
(12
)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

Purchases (7)
 
66

 
99

 
—

 
—

 
—

 
—

 
1

 
—

 
3

Sales (7)
 
(102
)
 
(66
)
 
—

 
(5
)
 
—

 
—

 
—

 
—

 
(1
)
Issuances (7)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Settlements (7)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(138
)
 
—

Transfers into Level 3 (8)
 
87

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Transfers out of Level 3 (8)
 
(137
)
 
(51
)
 
—

 
—

 
—

 
(14
)
 
—

 
—

 
—

Balance, end of period
 
$
1,906

 
$
1,206

 
$
—

 
$
—

 
$
123

 
$
—

 
$
(273
)
 
$
(1,293
)
 
$
7

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2019 (9)
 
$
—

 
$
(1
)
 
$
—

 
$
—

 
$
—

 
$
—

 
$
(8
)
 
$
(288
)
 
$
—

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2018 (9)
 
$
1

 
$
6

 
$
—

 
$
—

 
$
—

 
$
—

 
$
5

 
$
706

 
$
—

_______________
(1)
Comprised of U.S. and foreign corporate securities.
(2)
Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(3)
Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(4)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses).

37
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

(5)
Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).
(6)
Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
(7)
Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
(8)
Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(9)
Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).
Fair Value of Financial Instruments Carried at Other Than Fair Value
The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
 
March 31, 2019
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
14,504

 
$
—

 
$
—

 
$
14,822

 
$
14,822

Policy loans
$
1,385

 
$
—

 
$
622

 
$
961

 
$
1,583

Other invested assets
$
63

 
$
—

 
$
50

 
$
13

 
$
63

Premiums, reinsurance and other receivables
$
1,773

 
$
—

 
$
117

 
$
1,849

 
$
1,966

Liabilities
 
 
 
 
 
 
 
 
 
Policyholder account balances
$
15,283

 
$
—

 
$
—

 
$
14,334

 
$
14,334

Long-term debt
$
4,364

 
$
—

 
$
2,982

 
$
1,000

 
$
3,982

Other liabilities
$
861

 
$
—

 
$
639

 
$
222

 
$
861

Separate account liabilities
$
1,137

 
$
—

 
$
1,137

 
$
—

 
$
1,137


38
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

 
December 31, 2018
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
Level 1
 
Level 2
 
Level 3
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
13,694

 
$
—

 
$
—

 
$
13,860

 
$
13,860

Policy loans
$
1,421

 
$
—

 
$
656

 
$
959

 
$
1,615

Other invested assets
$
77

 
$
—

 
$
64

 
$
13

 
$
77

Premiums, reinsurance and other receivables
$
1,609

 
$
—

 
$
32

 
$
1,664

 
$
1,696

Liabilities
 
 
 
 
 
 
 
 
 
Policyholder account balances
$
15,332

 
$
—

 
$
—

 
$
13,861

 
$
13,861

Long-term debt
$
3,963

 
$
—

 
$
2,758

 
$
600

 
$
3,358

Other liabilities
$
330

 
$
—

 
$
118

 
$
212

 
$
330

Separate account liabilities
$
1,029

 
$
—

 
$
1,029

 
$
—

 
$
1,029

7. Long-term Debt
Term Loan Facility
On February 1, 2019, BHF entered into a new term loan agreement with respect to a new $1.0 billion five-year unsecured term loan facility (the “2019 Term Loan Facility”). On February 1, 2019, BHF borrowed $1.0 billion under the 2019 Term Loan Facility, terminated its former term loan facility due December 2, 2019 (the “2017 Term Loan Facility”) without penalty and repaid $600 million of borrowings outstanding under the 2017 Term Loan Facility, with the remainder of the proceeds to be used for general corporate purposes. Debt issuance costs incurred related to the 2019 Term Loan Facility were not significant.
8. Equity
Preferred Stock
On March 25, 2019, BHF issued depositary shares, each representing a 1/1,000th ownership interest in a share of BHF’s perpetual 6.600% Series A non-cumulative preferred stock (the “Series A Preferred Stock”) and in the aggregate representing 17,000 shares of Series A Preferred Stock, with a stated amount of $25,000 per share, for aggregate net cash proceeds of $412 million. Dividends, if declared, will accrue and be payable quarterly, in arrears, at an annual rate of 6.600% on the stated amount per share. In connection with the issuance of the depositary shares and the underlying Series A Preferred Stock, BHF incurred $13 million of issuance costs, which have been recorded as a reduction of additional paid-in capital.
Common Stock Repurchase Program
During the three months ended March 31, 2019, BHF repurchased 1,417,582 shares of its common stock through open market purchases, pursuant to a 10b5-1 plan, for $52 million. At March 31, 2019, BHF had $43 million remaining under its $200 million common stock repurchase program announced in August 2018.

39
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
8. Equity (continued)

Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI was as follows:
 
Three Months Ended
 March 31, 2019
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined Benefit Plans Adjustment
 
Total
 
(In millions)
Balance, December 31, 2018
$
576

 
$
187

 
$
(27
)
 
$
(20
)
 
$
716

OCI before reclassifications
1,252

 
(34
)
 
—

 
(3
)
 
1,215

Deferred income tax benefit (expense)
(263
)
 
7

 
—

 
—

 
(256
)
AOCI before reclassifications, net of income tax
1,565

 
160

 
(27
)
 
(23
)
 
1,675

Amounts reclassified from AOCI
19

 
(26
)
 
—

 
—

 
(7
)
Deferred income tax benefit (expense)
(4
)
 
6

 
—

 
—

 
2

Amounts reclassified from AOCI, net of income tax
15

 
(20
)
 
—

 
—

 
(5
)
Balance, March 31, 2019
$
1,580

 
$
140

 
$
(27
)
 
$
(23
)
 
$
1,670

 
Three Months Ended
 March 31, 2018
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined Benefit Plans Adjustment
 
Total
 
(In millions)
Balance, December 31, 2017
$
1,572

 
$
154

 
$
(24
)
 
$
(26
)
 
$
1,676

Cumulative effect of change in accounting principle, net of income tax
(79
)
 
—

 
—

 
—

 
(79
)
Balance, January 1, 2018
1,493

 
154

 
(24
)
 
(26
)
 
1,597

OCI before reclassifications
(1,073
)
 
(76
)
 
2

 
3

 
(1,144
)
Deferred income tax benefit (expense)
229

 
16

 
—

 
—

 
245

AOCI before reclassifications, net of income tax
649

 
94

 
(22
)
 
(23
)
 
698

Amounts reclassified from AOCI
58

 
(8
)
 
—

 
—

 
50

Deferred income tax benefit (expense)
(12
)
 
1

 
—

 
—

 
(11
)
Amounts reclassified from AOCI, net of income tax
46

 
(7
)
 
—

 
—

 
39

Balance, March 31, 2018
$
695

 
$
87

 
$
(22
)
 
$
(23
)
 
$
737

__________________
(1)
See Note 4 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI.

40
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
8. Equity (continued)

Information regarding amounts reclassified out of each component of AOCI was as follows:
AOCI Components
 
Amounts Reclassified from AOCI
 
Consolidated Statements of Operations and Comprehensive Income (Loss) Locations
 
 
Three Months Ended
 March 31,
 
 
 
 
2019
 
2018
 
 
 
 
(In millions)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
(15
)
 
$
(59
)
 
Net investment gains (losses)
Net unrealized investment gains (losses)
 
—

 
1

 
Net investment income
Net unrealized investment gains (losses)
 
(4
)
 
—

 
Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax
 
(19
)
 
(58
)
 
 
Income tax (expense) benefit
 
4

 
12

 
 
 Net unrealized investment gains (losses), net of income tax
 
(15
)
 
(46
)
 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
Interest rate swaps
 
22

 
6

 
Net derivative gains (losses)
Interest rate swaps
 
1

 
—

 
Net investment income
Interest rate forwards
 
—

 
1

 
Net derivative gains (losses)
Interest rate forwards
 
—

 
1

 
Net investment income
Foreign currency swaps
 
3

 
—

 
Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax
 
26

 
8

 
 
Income tax (expense) benefit
 
(6
)
 
(1
)
 
 
Gains (losses) on cash flow hedges, net of income tax
 
20

 
7

 
 
Total reclassifications, net of income tax
 
$
5

 
$
(39
)
 
 
9. Other Revenues and Other Expenses
Other Revenues
The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.
To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.
Other revenues consisted primarily of 12b-1 fees of $82 million and $93 million for the three months ended March 31, 2019 and 2018, respectively, of which substantially all were reported in the Annuities segment.

41
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
9. Other Revenues and Other Expenses (continued)

Other Expenses
Information on other expenses was as follows:
 
Three Months Ended
 March 31,
 
2019
 
2018
 
(In millions)
Compensation
$
81

 
$
70

Contracted services and other labor costs
47

 
49

Transition services agreements
66

 
74

Establishment costs
34

 
47

Premium and other taxes, licenses and fees
7

 
17

Separate account fees
119

 
136

Volume related costs, excluding compensation, net of DAC capitalization
165

 
159

Interest expense on debt
47

 
37

Other
26

 
29

Total other expenses
$
592

 
$
618

10. Earnings Per Common Share
The following table sets forth the calculation of earnings per common share:
 
Three Months Ended
 March 31,
 
2019
 
2018
 
(In millions, except share and per share data)
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders
$
(737
)
 
$
(67
)
Weighted average common shares outstanding:
 
 
 
Basic
116,805,384

 
119,773,106

Earnings per common share:
 
 
 
Basic
$
(6.31
)
 
$
(0.56
)
Basic loss per common share equaled diluted loss per common share for both the three months ended March 31, 2019 and 2018. The diluted shares were not utilized in the per share calculation, as the inclusion of such shares would have an antidilutive effect.

42
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)

11. Contingencies, Commitments and Guarantees
Contingencies
Litigation
The Company is a defendant in a number of litigation matters. In some of the matters, large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.
Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.
The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at March 31, 2019.
Matters as to Which an Estimate Can Be Made
For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of March 31, 2019, the Company estimates the aggregate range of reasonably possible losses in excess of amounts accrued for these matters to be $0 to $10 million.
Matters as to Which an Estimate Cannot Be Made
For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.
Sales Practices Claims
Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.
Summary
Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

43
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)
11. Contingencies, Commitments and Guarantees (continued)

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations, it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.
Commitments
Mortgage Loan Commitments
The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $335 million and $492 million at March 31, 2019 and December 31, 2018, respectively.
Commitments to Fund Partnership Investments, Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments
The Company commits to fund partnership investments and to lend funds under bank credit facilities and private corporate bond investments. The amounts of these unfunded commitments were $1.8 billion and $1.9 billion at March 31, 2019 and December 31, 2018, respectively.
Guarantees
In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $142 million, with a cumulative maximum of $148 million, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.
In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.
The Company’s recorded liabilities were $1 million and $2 million at March 31, 2019 and December 31, 2018, respectively, for indemnities, guarantees and commitments.

44
Brighthouse Financial, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) (continued)

12. Related Party Transactions
The following table summarizes income and expense from affiliated transactions with MetLife prior to the MetLife Divestiture (see Note 1) for the periods indicated:
 
Three Months Ended
 March 31,
 
2019
 
2018
 
(In millions)
Income (1)
$
—

 
$
(81
)
Expense (2)
$
—

 
$
78

__________________
(1)
Primarily includes the net impact of reinsurance ceded to MetLife.
(2)
Primarily includes costs incurred with MetLife related to shared services, offset by reinsurance ceded to MetLife.
13. Subsequent Events
Revolving Credit Facility
On May 7, 2019, BHF entered into an amended and restated revolving credit agreement (the “2019 Revolving Credit Agreement”) with respect to a $1.0 billion five-year senior unsecured revolving credit facility, all of which may be used for revolving loans and/or letters of credit. The 2019 Revolving Credit Agreement replaces BHF’s existing $2.0 billion five-year senior unsecured revolving credit agreement, which was scheduled to mature in December 2021.
Common Stock Repurchase Authorization
On May 3, 2019, BHF authorized the repurchase of up to an additional $400 million of common stock. Repurchases made under such authorization may be made through open market purchases, including pursuant to 10b5-1 plans or pursuant to accelerated stock repurchase plans, from time to time at management’s discretion in accordance with applicable federal securities laws. No common stock repurchases have been made under the May 3, 2019 authorization as of May 7, 2019.



45

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

46

Introduction
For purposes of this discussion, unless otherwise mentioned or unless the context indicates otherwise, “Brighthouse,” “Brighthouse Financial,” the “Company,” “we,” “our” and “us” refer to Brighthouse Financial, Inc. a corporation incorporated in Delaware in 2016, and its subsidiaries. We use the term “BHF” to refer solely to Brighthouse Financial, Inc., and not to any of its subsidiaries. Until August 4, 2017, BHF was a wholly-owned subsidiary of MetLife, Inc. (together with its subsidiaries and affiliates, “MetLife”). Following this summary is a discussion addressing the consolidated results of operations and financial condition of the Company for the periods indicated. This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with (i) the unaudited interim condensed consolidated financial statements and related notes included elsewhere herein; (ii) our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the U.S. Securities and Exchange Commission (“SEC”) on February 26, 2019 (the “2018 Annual Report”); and (iii) our current reports on Form 8-K filed in 2019.
The term “Separation” refers to the separation of MetLife’s former Brighthouse Financial segment from MetLife’s other businesses and the creation of a separate, publicly traded company, BHF, as well as the distribution on August 4, 2017 of 96,776,670, or 80.8%, of the 119,773,106 shares of BHF common stock outstanding immediately prior to the distribution date by MetLife, Inc. to holders of MetLife, Inc. common stock as of the record date for the distribution. The term “MetLife Divestiture” refers to the disposition by MetLife, Inc. on June 14, 2018 of all its remaining shares of BHF common stock. Effective with the MetLife Divestiture, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties to Brighthouse Financial, Inc. and its subsidiaries and affiliates.
Presentation
Prior to discussing our Results of Operations, we present background information and definitions that we believe are useful to understanding the discussion of our financial results. This information precedes the Results of Operations and is most beneficial when read in the sequence presented. A summary of key informational sections is as follows:
•
“Executive Summary” provides information regarding our business, segments and results as discussed in the Results of Operations.
•
“Industry Trends” discusses updates and changes to a number of trends and uncertainties included in the 2018 Annual Report that we believe may materially affect our future financial condition, results of operations or cash flows.
•
“Summary of Critical Accounting Estimates” explains the most critical estimates and judgments applied in determining our GAAP results.
•
“Non-GAAP and Other Financial Disclosures” defines key financial measures presented in the Results of Operations that are not calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”) but are used by management in evaluating company and segment performance. As described in this section, adjusted earnings is presented by key business activities which are derived from, but different than, the line items presented in the GAAP statement of operations. This section also refers to certain other terms used to describe our insurance business and financial and operating metrics, but is not intended to be exhaustive.
Certain amounts presented in prior periods within the foregoing discussions of our financial results have been reclassified to conform with the current year presentation.

47

Executive Summary
We are one of the largest providers of annuity and life insurance products in the United States through multiple independent distribution channels and marketing arrangements with a diverse network of distribution partners.
For operating purposes, we have established three segments: (i) Annuities, (ii) Life and (iii) Run-off, which consists of operations relating to products we are not actively selling and which are separately managed. In addition, we report certain of our results of operations in Corporate & Other.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to help the reader understand the results of operations, financial condition and cash flows of Brighthouse for the periods indicated. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Executive Summary — Overview,” and “Business — Segments and Corporate & Other” included in the 2018 Annual Report along with Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements for further information on our segments and Corporate & Other.
The table below presents a summary of our net income (loss) available to shareholders and adjusted earnings, a non-GAAP financial measure. See “— Non-GAAP and Other Financial Disclosures.” For a detailed discussion of our results see “— Results of Operations.”
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
(In millions)
Net income (loss) available to shareholders before provision for income tax
 
$
(955
)
 
$
(115
)
Less: Provision for income tax expense (benefit)
 
(218
)
 
(48
)
Net income (loss) available to shareholders
 
$
(737
)
 
$
(67
)
 
 
 
 
 
Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
$
272

 
$
328

Less: Provision for income tax expense (benefit)
 
40

 
45

Adjusted earnings
 
$
232

 
$
283

For the three months ended March 31, 2019, we had a net loss available to shareholders of $737 million and adjusted earnings of $232 million, compared to a net loss available to shareholders of $67 million and adjusted earnings of $283 million for the three months ended March 31, 2018. The net loss available to shareholders for the three months ended March 31, 2019 was driven primarily by net derivative losses resulting from higher equity markets, net of the impacts from a decline in interest rates, and lower adjusted earnings.
See Note 1 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding the adoption of new accounting pronouncements in 2019.
Industry Trends
Throughout this Management’s Discussion and Analysis of Financial Condition and Results of Operations, we discuss a number of trends and uncertainties that we believe may materially affect our future financial condition, results of operations or cash flows. Where these trends or uncertainties are specific to a particular aspect of our business, we often include such a discussion under the relevant caption of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, as part of our broader analysis of that area of our business. Refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends and Uncertainties” included in the 2018 Annual Report, for a comprehensive discussion of some of the key general trends and uncertainties that have influenced the development of our business and our historical financial performance and that we believe will continue to influence our business and results of operations in the future.

48

Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Consolidated Financial Statements.
The most critical estimates include those used in determining:
(i)
liabilities for future policy benefits;
(ii)
accounting for reinsurance;
(iii)
capitalization and amortization of deferred policy acquisition costs (“DAC”) and amortization of value of business acquired (“VOBA”);
(iv)
estimated fair values of investments in the absence of quoted market values;
(v)
investment impairments;
(vi)
estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;
(vii)
measurement of income taxes and the valuation of deferred tax assets; and
(viii)
liabilities for litigation and regulatory matters.
In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.
The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” and Note 1 of the Notes to the Consolidated and Combined Financial Statements included in the 2018 Annual Report.
Non-GAAP and Other Financial Disclosures
Our definitions of the non-GAAP and other financial measures may differ from those used by other companies.
Non-GAAP Financial Disclosures
Adjusted Earnings
In this report, we present adjusted earnings, which excludes net income (loss) attributable to noncontrolling interests, as a measure of our performance that is not calculated in accordance with GAAP. We believe that this non-GAAP financial measure highlights our results of operations and the underlying profitability drivers of our business, as well as enhances the understanding of our performance by the investor community. However, adjusted earnings should not be viewed as a substitute for net income (loss) available to Brighthouse Financial, Inc.’s common shareholders, which is the most directly comparable financial measure calculated in accordance with GAAP. See “— Results of Operations” for a reconciliation of adjusted earnings to net income (loss) available to Brighthouse Financial, Inc.’s common shareholders.
Adjusted earnings, which may be positive or negative, is used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. This financial measure focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends.
The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:
•
Net investment gains (losses);
•
Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and
•
Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).
The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:
•
Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);

49

•
Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and
•
Amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.
The tax impact of the adjustments mentioned is calculated net of the statutory tax rate, which could differ from our effective tax rate.
We present adjusted earnings in a manner consistent with management’s view of the primary business activities that drive the profitability of our core businesses. The following table illustrates how each component of adjusted earnings is calculated from the GAAP statement of operations line items:
Component of Adjusted Earnings
How Derived from GAAP (1)
(i)
Fee income
(i)
Universal life and investment-type policy fees (excluding (a) unearned revenue adjustments related to net investment gains (losses) and net derivative gains (losses) and (b) GMIB Fees) plus Other revenues (excluding other revenues associated with related party reinsurance) and amortization of deferred gain on reinsurance.
(ii)
Net investment spread
(ii)
Net investment income plus Investment Hedge Adjustments and interest received on ceded fixed annuity reinsurance deposit funds reduced by Interest credited to policyholder account balances and interest on future policy benefits.
(iii)
Insurance-related activities
(iii)
Premiums less Policyholder benefits and claims (excluding (a) GMIB Costs, (b) Market Value Adjustments, (c) interest on future policy benefits and (d) amortization of deferred gain on reinsurance) plus the pass through of performance of ceded separate account assets.
(iv)
Amortization of DAC and VOBA
(iv)
Amortization of DAC and VOBA (excluding amounts related to (a) net investment gains (losses), (b) net derivative gains (losses), (c) GMIB Fees and GMIB Costs and (d) Market Value Adjustments).
(v)
Other expenses, net of DAC capitalization
(v)
Other expenses reduced by capitalization of DAC.
(vi)
Provision for income tax expense (benefit)
(vi)
Tax impact of the above items.
______________
(1)
Italicized items indicate GAAP statement of operations line items.
Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance. Accordingly, we report adjusted earnings by segment in Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements.
Adjusted Net Investment Income
We present adjusted net investment income, which is not calculated in accordance with GAAP. We present adjusted net investment income to measure our performance for management purposes, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents net investment income including investment hedge adjustments. For a reconciliation of adjusted net investment income to net investment income, the most directly comparable GAAP measure, see footnote 3 to the summary yield table located in “— Investments — Current Environment — Investment Portfolio Results.”
Other Financial Disclosures
The following additional information is relevant to an understanding of our performance results:
•
We sometimes refer to sales activity for various products. Statistical sales information for life sales are calculated using the LIMRA (Life Insurance Marketing and Research Association) definition of sales for core direct sales, excluding company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. Annuity sales consist of 10% of direct statutory premiums, excluding company sponsored internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.
•
Similar to adjusted net investment income, we present net investment income yields as a performance measure we believe enhances the understanding of our investment portfolio results. Net investment income yields are calculated

50

on adjusted net investment income as a percent of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets, and collateral received from derivative counterparties.

51

Results of Operations
Consolidated Results for the Three Months Ended March 31, 2019 and 2018
Business Overview. Annuity sales increased 36% compared to the prior period driven by higher sales of our suite of structured annuities consisting of products marketed under various names (collectively, “Shield Annuities”), fixed indexed annuities and fixed annuities.
Unless otherwise noted, all amounts in the following discussions of our results of operations are stated before income tax except for adjusted earnings, which are presented net of income tax.
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Revenues
 
 
 
 
Premiums
 
$
227

 
$
229

Universal life and investment-type product policy fees
 
875

 
1,002

Net investment income
 
811

 
817

Other revenues
 
92

 
105

Net investment gains (losses)
 
(11
)
 
(4
)
Net derivative gains (losses)
 
(1,303
)
 
(334
)
Total revenues
 
691

 
1,815

Expenses
 
 
 
 
Policyholder benefits and claims
 
772

 
738

Interest credited to policyholder account balances
 
258

 
267

Capitalization of DAC
 
(86
)
 
(76
)
Amortization of DAC and VOBA
 
22

 
305

Interest expense on debt
 
47

 
37

Other expenses
 
631

 
657

Total expenses
 
1,644

 
1,928

Income (loss) before provision for income tax
 
(953
)
 
(113
)
Provision for income tax expense (benefit)
 
(218
)
 
(48
)
Net income (loss)
 
(735
)
 
(65
)
Less: Net income (loss) attributable to noncontrolling interests
 
2

 
2

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders
 
$
(737
)
 
$
(67
)

52

The table below shows the components of net income (loss) available to shareholders.
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
GMLB Riders
 
$
(1,330
)
 
$
6

Other derivative instruments
 
136

 
(477
)
Net investment gains (losses)
 
(11
)
 
(4
)
Other adjustments
 
(22
)
 
32

Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
272

 
328

Net income (loss) available to shareholders before provision for income tax
 
(955
)
 
(115
)
Provision for income tax expense (benefit)
 
(218
)
 
(48
)
Net income (loss) available to shareholders
 
$
(737
)
 
$
(67
)
Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Net loss available to shareholders before provision for income tax was $955 million ($737 million, net of income tax), an increased loss of $840 million ($670 million, net of income tax) from a loss before provision for income tax of $115 million ($67 million, net of income tax) in the prior period.
The increased loss was driven by the following key unfavorable items:
•
guaranteed minimum living benefits (“GMLB”) Riders, discussed in detail in “— GMLB Riders for the Three Months Ended March 31, 2019 and 2018;”
•
higher policyholder benefits and claims, included in other adjustments, resulting from the adjustment for market performance related to participating products in the Run-off segment; and
•
lower adjusted earnings, which is discussed in greater detail below.
The increased loss in income before provision for income tax was partially offset by current period gains on interest rate swaps and swaptions in our universal life with secondary guarantees (“ULSG”) Hedge Program from declining long-term interest rates.
The provision for income tax in the current period led to an effective tax rate of 23%, compared to 42% in the prior period, and primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

53

Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings
Three Months Ended March 31, 2019
 
 
Annuities
 
Life
 
Run-off
 
Corporate & Other
 
Total
 
 
(In millions)
Net income (loss) available to shareholders
 
$
(1,051
)
 
$
16

 
$
258

 
$
40

 
$
(737
)
Add: Provision for income tax expense (benefit)
 
55

 
6

 
(148
)
 
(131
)
 
(218
)
Net income (loss) available to shareholders before provision for income tax
 
(996
)
 
22

 
110

 
(91
)
 
(955
)
Less: GMLB Riders
 
(1,330
)
 
—

 
—

 
—

 
(1,330
)
Less: Other derivative instruments
 
(32
)
 
10

 
158

 
—

 
136

Less: Net investment gains (losses)
 
4

 
(19
)
 
21

 
(17
)
 
(11
)
Less: Other adjustments
 
1

 
—

 
(23
)
 
—

 
(22
)
Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
361

 
31

 
(46
)
 
(74
)
 
272

Less: Provision for income tax expense (benefit)
 
66

 
6

 
(10
)
 
(22
)
 
40

Adjusted earnings
 
$
295

 
$
25

 
$
(36
)
 
$
(52
)
 
$
232

Three Months Ended March 31, 2018
 
 
Annuities
 
Life
 
Run-off
 
Corporate & Other
 
Total
 
 
(In millions)
Net income (loss) available to shareholders
 
$
243

 
$
90

 
$
(262
)
 
$
(138
)
 
$
(67
)
Add: Provision for income tax expense (benefit)
 
51

 
23

 
(97
)
 
(25
)
 
(48
)
Net income (loss) available to shareholders before provision for income tax
 
294

 
113

 
(359
)
 
(163
)
 
(115
)
Less: GMLB Riders
 
6

 
—

 
—

 
—

 
6

Less: Other derivative instruments
 
(22
)
 
(14
)
 
(420
)
 
(21
)
 
(477
)
Less: Net investment gains (losses)
 
36

 
46

 
(32
)
 
(54
)
 
(4
)
Less: Other adjustments
 
2

 
—

 
30

 
—

 
32

Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
272

 
81

 
63

 
(88
)
 
328

Less: Provision for income tax expense (benefit)
 
46

 
15

 
13

 
(29
)
 
45

Adjusted earnings
 
$
226

 
$
66

 
$
50

 
$
(59
)
 
$
283


54

Consolidated Results for the Three Months Ended March 31, 2019 and 2018 — Adjusted Earnings
The following table presents the components of adjusted earnings:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
(In millions)
Fee income
 
$
901

 
$
1,036

Net investment spread
 
335

 
344

Insurance-related activities
 
(273
)
 
(255
)
Amortization of DAC and VOBA
 
(97
)
 
(177
)
Other expenses, net of DAC capitalization
 
(592
)
 
(618
)
Less: Net income (loss) attributable to noncontrolling interests
 
2

 
2

Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
272

 
328

Provision for income tax expense (benefit)
 
40

 
45

Adjusted earnings
 
$
232

 
$
283

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Adjusted earnings decreased $51 million.
Key net unfavorable impacts were:
•
lower fee income due to:
◦
lower asset-based and advisory fees from lower average separate account balances in our Annuity segment, some of which is passed through to third-parties and offset in other expense in the current period, and
◦
the reimbursement of fees for recaptured universal life business in the prior period;
•
higher costs associated with insurance-related activities due to:
◦
unfavorable mortality in our life business;
partially offset by
◦
a decrease in guaranteed minimum death benefits (“GMDB”) liability balances resulting from positive equity market performance;
•
lower net investment spread reflecting:
◦
lower alternative investment income in the current period;
partially offset by
◦
higher average invested assets resulting from positive net flows in the general account, and
◦
repositioning of the investment portfolio into higher yielding assets.
The decrease in adjusted earnings was partially offset by the following favorable impacts:
•
lower amortization of DAC and VOBA primarily due to positive equity market performance in the current period, and
•
lower other expenses due to:
◦
lower asset-based variable annuity expenses resulting from lower average separate account balances, which are passed through to third-parties and largely offset in fee income, and
◦
lower establishment costs related to planned technology and branding expenses associated with the Separation.
The provision for income tax in the current period led to an effective tax rate of 15%, compared to 14% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

55

Segments and Corporate & Other Results for the Three Months Ended March 31, 2019 and 2018 — Adjusted Earnings
Annuities
The following table presents the components of adjusted earnings for our Annuities segment:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Fee income
 
$
638

 
$
731

Net investment spread
 
241

 
175

Insurance-related activities
 
(42
)
 
(85
)
Amortization of DAC and VOBA
 
(82
)
 
(143
)
Other expenses, net of DAC capitalization
 
(394
)
 
(406
)
Pre-tax adjusted earnings
 
361

 
272

Provision for income tax expense (benefit)
 
66

 
46

Adjusted earnings
 
$
295

 
$
226

A significant portion of our adjusted earnings is driven by separate account balances related to our variable annuity business. Most directly, these balances determine asset-based fee income but they also impact DAC amortization and asset-based commissions. Below is a rollforward of our variable annuities separate account balances. Variable annuities separate account balances increased as of March 31, 2019 compared to December 31, 2018 driven by an increase in equity market performance, partially offset by negative net flows and policy charges.
 
 
Three Months Ended
 
 
March 31, 2019
 
December 31, 2018
 
 
(In millions)
Balance, beginning of period
 
$
91,922

 
$
104,575

Deposits
 
299

 
326

Withdrawals, surrenders and contract benefits
 
(2,284
)
 
(2,526
)
Net flows
 
(1,985
)
 
(2,200
)
Investment performance
 
8,926

 
(9,758
)
Policy charges
 
(569
)
 
(634
)
Net transfers from (to) general account
 
(51
)
 
(61
)
Balance, end of period
 
$
98,243

 
$
91,922

 
 
 
 
 
Average balance
 
$
96,471

 
$
97,167

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Adjusted earnings were $295 million for the current period, an increase of $69 million.
Key net favorable impacts were:
•
higher net investment spread driven by:
◦
higher average invested assets resulting from positive net flows in the general account, and
◦
repositioning of the investment portfolio into higher yielding assets;
•
lower amortization of DAC and VOBA driven by:
◦
positive equity market performance in the current period and
◦
the net impacts of actuarial model refinements in both the current and prior periods;
•
lower costs associated with insurance-related activities due to a decrease in GMDB liability balances resulting from positive equity market performance, net of higher volume and severity of claims in the current period; and

56

•
lower other expenses due to:
◦
lower asset-based variable annuity expenses resulting from lower average separate account balances, which are passed through to third-parties and largely offset in fee income,
partially offset by
◦
a change in allocation between segments.
The increase in adjusted earnings was partially offset by the lower fee income due to lower asset-based fees resulting from lower average separate account balances, a portion of which are offset in other expenses.
The provision for income tax in the current period led to an effective tax rate of 18%, compared to 17% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

Life
The following table presents the components of adjusted earnings for our Life segment:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Fee income
 
$
61

 
$
103

Net investment spread
 
42

 
46

Insurance-related activities
 
(6
)
 
24

Amortization of DAC and VOBA
 
(11
)
 
(29
)
Other expenses, net of DAC capitalization
 
(55
)
 
(63
)
Pre-tax adjusted earnings
 
31

 
81

Provision for income tax expense (benefit)
 
6

 
15

Adjusted earnings
 
$
25

 
$
66

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Adjusted earnings were $25 million for the current period, a decrease of $41 million.
Key net unfavorable impacts were:
•
lower fee income due to:
◦
the reimbursement of fees for recaptured universal life business in the prior period, and
◦
lower unearned revenue in the current period from positive separate account fund performance, which was more than offset in amortization of DAC and VOBA;
•
higher costs associated with insurance-related activities due to higher paid claims, net of reinsurance.
The decrease in adjusted earnings was partially offset by lower amortization of DAC and VOBA primarily due to positive separate account fund performance in the current period.
The provision for income tax led to an effective tax rate of 19% in both the current and prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

57

Run-off
The following table presents the components of adjusted earnings for our Run-off segment:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
 
(In millions)
Fee income
 
$
199

 
$
205

Net investment spread
 
35

 
112

Insurance-related activities
 
(234
)
 
(206
)
Amortization of DAC and VOBA
 
—

 
—

Other expenses, net of DAC capitalization
 
(46
)
 
(48
)
Pre-tax adjusted earnings
 
(46
)
 
63

Provision for income tax expense (benefit)
 
(10
)
 
13

Adjusted earnings
 
$
(36
)
 
$
50

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Adjusted earnings were a loss of $36 million for the current period, a decrease of $86 million.
Key net unfavorable impacts were:
•
lower net investment spread reflecting lower alternative investment income in the current period;
•
higher costs associated with insurance-related activities due to unfavorable mortality in our ULSG business resulting from lower reinsurance recoveries in the current period, and
•
lower fee income due to:
◦
the reimbursement of fees for recaptured ULSG business;
partially offset by
◦
the ongoing impacts of various reinsurance recaptures, which occurred in the prior period.
The provision for income tax in the current period led to an effective tax rate of 22%, compared to 21% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

58

Corporate & Other
The following table presents the components of adjusted earnings for Corporate & Other:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
(In millions)
Fee income
 
$
3

 
$
(3
)
Net investment spread
 
17

 
11

Insurance-related activities
 
9

 
12

Amortization of DAC and VOBA
 
(4
)
 
(5
)
Other expenses, net of DAC capitalization
 
(97
)
 
(101
)
Less: Net income (loss) attributable to noncontrolling interests
 
2

 
2

Pre-tax adjusted earnings, less net income attributable to noncontrolling interests
 
(74
)
 
(88
)
Provision for income tax expense (benefit)
 
(22
)
 
(29
)
Adjusted earnings
 
$
(52
)
 
$
(59
)
Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Adjusted earnings were a loss of $52 million, an improvement of $7 million from the prior period.
Key net favorable impacts were:
•
higher net investment spread reflecting positive returns on short-term investments, and
•
lower other expenses due to:
◦
lower establishment costs related to planned technology expenses,
partially offset by
◦
higher interest on debt which was issued in the third quarter of 2018.
The provision for income tax in the current period led to an effective tax rate of 30%, compared to 33% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

59

GMLB Riders for the Three Months Ended March 31, 2019 and 2018
The following table presents the overall impact to income (loss) available to shareholders before provision for income tax from the performance of GMLB Riders, which includes (i) changes in carrying value of the GAAP liabilities, (ii) the mark-to-market of hedges and reinsurance, (iii) fees, and (iv) associated DAC offsets:
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
(In millions)
Liabilities (1)
 
$
(348
)
 
$
333

Hedging Program
 
(1,245
)
 
(371
)
Ceded Reinsurance
 
(9
)
 
(28
)
Fees (2)
 
198

 
205

GMLB DAC
 
74

 
(133
)
Total GMLB Riders
 
$
(1,330
)
 
$
6

______________
(1)
Includes changes in fair value of the Shield Annuities embedded derivatives of ($699) million and $58 million for the three months ended March 31, 2019 and 2018, respectively.
(2)
Excludes living benefit fees, included as a component of adjusted earnings, of $16 million and $18 million for the three months ended March 31, 2019 and 2018, respectively.
Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018
Comparative results from GMLB Riders were unfavorable by $1.3 billion. This change was mostly driven by higher equity market performance which impacted the following:
•
an unfavorable change in the fair value of equity derivatives in our GMLB Hedging Program and
•
an unfavorable change in the fair value of the Shield Annuities embedded derivatives;
partially offset by
•
a favorable change in GMLB DAC.

60

Investments
Investment Risks
Our primary investment objective is to optimize risk-adjusted net investment income and risk-adjusted total return while appropriately matching assets and liabilities. In addition, the investment process is designed to ensure that the portfolio has an appropriate level of liquidity, quality and diversification.
We are exposed to the following primary sources of investment risks:
•
credit risk, relating to the uncertainty associated with the continued ability of a given obligor to make timely payments of principal and interest;
•
interest rate risk, relating to the market price and cash flow variability associated with changes in market interest rates. Changes in market interest rates will impact the net unrealized gain or loss position of our fixed income investment portfolio and the rates of return we receive on both new funds invested and reinvestment of existing funds;
•
market valuation risk, relating to the variability in the estimated fair value of investments associated with changes in market factors such as credit spreads and equity market levels. A widening of credit spreads will adversely impact the net unrealized gain (loss) position of the fixed income investment portfolio, will increase losses associated with credit-based non-qualifying derivatives where we assume credit exposure, and, if credit spreads widen significantly or for an extended period of time, will likely result in higher other-than-temporary impairment (“OTTI”). Credit spread tightening will reduce net investment income associated with new purchases of fixed maturity securities and will favorably impact the net unrealized gain (loss) position of the fixed income investment portfolio;
•
liquidity risk, relating to the diminished ability to sell certain investments, in times of strained market conditions;
•
real estate risk, relating to commercial, agricultural and residential real estate, and stemming from factors, which include, but are not limited to, market conditions, including the demand and supply of leasable commercial space, creditworthiness of borrowers and their tenants and joint venture partners, capital markets volatility and inherent interest rate movements;
•
currency risk, relating to the variability in currency exchange rates for foreign denominated investments; and
•
financial and operational integration risks while we transition to a multiple manager investment platform, and following such transition, we will continue to be subject to the risks related to using external investment managers.
We manage these risks through asset-type allocation and industry and issuer diversification. Risk limits are also used to promote diversification by asset sector, avoid concentrations in any single issuer and limit overall aggregate credit and equity risk exposure. Real estate risk is managed through geographic and property type and product type diversification. We manage interest rate risk as part of our Asset Liability Management (“ALM”) strategies. Product design, such as the use of market value adjustment features and surrender charges, is also utilized to manage interest rate risk. These strategies include maintaining an investment portfolio with diversified maturities that targets a weighted average duration that reflects the duration of our estimated liability cash flow profile. For certain of our liability portfolios, it is not possible to invest assets to the full liability duration, thereby creating some asset/liability mismatch. We also use certain derivatives in the management of currency, credit, interest rate, and equity market risks.
Investment Management Agreements
Following the Separation, MetLife Investment Advisors (“MLIA”) managed our investment portfolio pursuant to several investment management agreements. On February 5, 2019, we terminated several existing investment management agreements with MLIA and entered into a new investment management agreement (the “Investment Management Agreement”) with MLIA, pursuant to which MLIA will, on a sub-advisory basis, manage the investment of the assets comprising the general account portfolio and certain separate account assets of our insurance subsidiaries, as well as assets of BHF and our non-insurance subsidiaries. As part of the termination of the prior investment management agreements, we brought our derivatives trading, which had previously been managed by MLIA, in-house. The Investment Management Agreement marks one of the initial steps in the transition of our investment portfolio to a multi-manager platform, which is expected to continue in stages throughout 2019. The Investment Management Agreement allows us flexibility to partially terminate investment management services for specified investments upon prior notice to MLIA and we have accordingly terminated certain services under the Investment Management Agreement as we have engaged a select group of experienced external asset management firms to provide such services.

61

Current Environment
Our business and results of operations are materially affected by conditions in capital markets and the economy, generally. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends and Uncertainties — Financial and Economic Environment” included in the 2018 Annual Report.
As a U.S. insurance company, we are affected by the monetary policy of the Federal Reserve Board in the United States. The Federal Open Market Committee has increased the federal funds rate six times since the start of 2017. The Federal Reserve may take further actions to influence interest rates in the future, which may have an impact on the pricing levels of risk-bearing investments and may adversely impact the level of product sales. We are also affected by the monetary policy of central banks around the world due to the diversification of our investment portfolio.
Investment Portfolio Results
The following summary yield table presents the yield and net investment income for our investment portfolio for the periods indicated. As described below, this table reflects certain differences from the presentation of net investment income presented in the GAAP statement of operations. This summary yield table presentation is consistent with how we measure our investment performance for management purposes, and we believe it enhances understanding of our investment portfolio results.
 
Three Months Ended
 March 31,
 
2019
 
2018
 
Yield% (1)
 
Amount
 
Yield% (1)
 
Amount
 
(Dollars in millions)
Investment income
4.24
 %
 
$
839

 
4.65
 %
 
$
852

Investment fees and expenses
(0.14
)
 
(28
)
 
(0.15
)
 
(27
)
Adjusted net investment income (2), (3)
4.10
 %
 
$
811

 
4.50
 %
 
$
825

_______________
(1)
Yields are calculated as investment income as a percent of average quarterly asset carrying values. Investment income excludes recognized gains and losses and reflects the adjustments presented in footnote 3 below to arrive at adjusted net investment income. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.
(2)
Adjusted net investment income included in yield calculations includes Investment Hedge Adjustments.
(3)
Adjusted net investment income presented in the yield table varies from the most directly comparable GAAP measure due to certain reclassifications, as presented below.
 
 
Three Months Ended
 March 31,
 
 
2019
 
2018
 
(In millions)
Net investment income
 
$
811

 
$
817

Less: Investment hedge adjustments
 
—

 
(8
)
Adjusted net investment income — in the above yield table
 
$
811

 
$
825

See “— Results of Operations — Consolidated Results for the Three Months Ended March 31, 2019 and 2018 — Adjusted Earnings” for an analysis of the period over period changes in net investment income.

62

Fixed Maturity Securities AFS
The following table presents fixed maturity securities available-for-sale (“AFS”) by type (public or private) held at:
 
 
March 31, 2019
 
December 31, 2018
 
 
Estimated
Fair Value
 
% of
Total
 
Estimated
Fair Value
 
% of
Total
 
 
(Dollars in millions)
Fixed maturity securities
 
 
 
 
 
 
 
 
Publicly-traded
 
$
53,408

 
82.4
%
 
$
51,939

 
83.0
%
Privately-placed
 
11,439

 
17.6

 
10,669

 
17.0

Total fixed maturity securities
 
$
64,847

 
100.0
%
 
$
62,608

 
100.0
%
Percentage of cash and invested assets
 
72.0
%
 
 

 
71.7
%
 
 

Valuation of Securities. See Note 6 of the Notes to the Interim Condensed Consolidated Financial Statements for further information on our valuation controls and procedures including our formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value.
Fixed Maturity Securities AFS
See Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements for information about fixed maturity securities AFS by sector, contractual maturities and continuous gross unrealized losses.
Fixed Maturity Securities Credit Quality — Ratings
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Fixed Maturity AFS — Fixed Maturity Securities Credit Quality — Ratings” included in the 2018 Annual Report for a discussion of the credit quality ratings assigned by Nationally Recognized Statistical Rating Organizations (“NRSRO”), credit quality designations assigned by and methodologies used by the Securities Valuation Office of the National Association of Insurance Commissioners (“NAIC”) for fixed maturity securities and the revised methodologies adopted by the NAIC for certain residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).
The following table presents total fixed maturity securities by NRSRO rating and the applicable NAIC designation from the NAIC published comparison of NRSRO ratings to NAIC designations, except for certain Structured Securities, which are presented using the revised NAIC methodologies, as well as the percentage, based on estimated fair value that each NAIC designation is comprised of at:
 
 
 
 
March 31, 2019
 
December 31, 2018
NAIC
Designation
 
NRSRO Rating
 
Amortized
Cost
 
Unrealized
Gain (Loss)
 
Estimated Fair Value
 
% of
Total
 
Amortized
Cost
 
Unrealized
Gain (Loss)
 
Estimated Fair Value
 
% of
Total
 
 
 
 
(Dollars in millions)
1
 
Aaa/Aa/A
 
$
39,949

 
$
3,240

 
$
43,189

 
66.6
%
 
$
40,218

 
$
1,954

 
$
42,172

 
67.4
%
2
 
Baa
 
18,123

 
521

 
18,644

 
28.8

 
17,656

 
(122
)
 
17,534

 
28.0

Subtotal investment grade
 
58,072

 
3,761

 
61,833

 
95.4

 
57,874

 
1,832

 
59,706

 
95.4

3
 
Ba
 
2,092

 
3

 
2,095

 
3.2

 
2,160

 
(87
)
 
2,073

 
3.3

4
 
B
 
834

 
(8
)
 
826

 
1.3

 
787

 
(48
)
 
739

 
1.2

5
 
Caa and lower
 
70

 
(5
)
 
65

 
0.1

 
99

 
(9
)
 
90

 
0.1

6
 
In or near default
 
33

 
(5
)
 
28

 
—

 
—

 
—

 
—

 
—

Subtotal below investment grade
 
3,029

 
(15
)
 
3,014

 
4.6

 
3,046

 
(144
)
 
2,902

 
4.6

Total fixed maturity securities
 
$
61,101

 
$
3,746

 
$
64,847

 
100.0
%
 
$
60,920

 
$
1,688

 
$
62,608

 
100.0
%

63

The following tables present total fixed maturity securities, based on estimated fair value, by sector classification and by NRSRO rating and the applicable NAIC designations from the NAIC published comparison of NRSRO ratings to NAIC designations, except for certain Structured Securities, which are presented using the NAIC methodologies as described above:
 
 
Fixed Maturity Securities — by Sector & Credit Quality Rating
NAIC Designation
 
1
 
2
 
3
 
4
 
5
 
6
 
Total
Estimated
Fair Value
NRSRO Rating
 
Aaa/Aa/A
 
Baa
 
Ba
 
B
 
Caa and
Lower
 
In or Near
Default
 
 
 
(Dollars in millions)
March 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
 
$
12,236

 
$
11,476

 
$
1,391

 
$
694

 
$
31

 
$
28

 
$
25,856

U.S. government and agency
 
8,012

 
76

 
—

 
—

 
—

 
—

 
8,088

RMBS
 
8,754

 
56

 
51

 
1

 
21

 
—

 
8,883

Foreign corporate
 
2,763

 
5,720

 
488

 
92

 
10

 
—

 
9,073

CMBS
 
5,325

 
102

 
—

 
—

 
—

 
—

 
5,427

State and political subdivision
 
3,642

 
161

 
1

 
4

 
3

 
—

 
3,811

ABS
 
1,747

 
298

 
33

 
—

 
—

 
—

 
2,078

Foreign government
 
710

 
755

 
131

 
35

 
—

 
—

 
1,631

Total fixed maturity securities
 
$
43,189

 
$
18,644

 
$
2,095

 
$
826

 
$
65

 
$
28

 
$
64,847

Percentage of total
 
66.6
%
 
28.8
%
 
3.2
%
 
1.3
%
 
0.1
%
 
—
%
 
100.0
%
December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
 
$
11,277

 
$
11,118

 
$
1,417

 
$
635

 
$
26

 
$
—

 
$
24,473

U.S. government and agency
 
8,921

 
174

 
—

 
—

 
—

 
—

 
9,095

RMBS
 
8,395

 
40

 
58

 
6

 
48

 
—

 
8,547

Foreign corporate
 
2,427

 
5,089

 
427

 
70

 
13

 
—

 
8,026

CMBS
 
5,183

 
57

 
6

 
2

 
—

 
—

 
5,248

State and political subdivision
 
3,437

 
156

 
1

 
—

 
3

 
—

 
3,597

ABS
 
1,851

 
244

 
30

 
1

 
—

 
—

 
2,126

Foreign government
 
681

 
656

 
134

 
25

 
—

 
—

 
1,496

Total fixed maturity securities
 
$
42,172

 
$
17,534

 
$
2,073

 
$
739

 
$
90

 
$
—

 
$
62,608

Percentage of total
 
67.4
%
 
28.0
%
 
3.3
%
 
1.2
%
 
0.1
%
 
—
%
 
100.0
%
U.S. and Foreign Corporate Fixed Maturity Securities
We maintain a diversified portfolio of corporate fixed maturity securities across industries and issuers. This portfolio does not have any exposure to any single issuer in excess of 1% of total investments and the top ten holdings in aggregate comprise 2% of total investments at both March 31, 2019 and December 31, 2018. The tables below present our U.S. and foreign corporate securities holdings by industry at:
 
 
March 31, 2019
 
December 31, 2018
 
 
Estimated
Fair Value
 
% of
Total
 
Estimated
Fair Value
 
% of
Total
 
 
(Dollars in millions)
Industrial
 
$
10,581

 
30.3
%
 
$
9,896

 
30.4
%
Consumer
 
9,018

 
25.8

 
8,290

 
25.5

Finance
 
7,690

 
22.0

 
7,209

 
22.2

Utility
 
5,142

 
14.7

 
4,770

 
14.7

Communications
 
2,498

 
7.2

 
2,334

 
7.2

Total
 
$
34,929

 
100.0
%
 
$
32,499

 
100.0
%

64

Structured Securities
We held $16.4 billion and $15.9 billion of Structured Securities, at estimated fair value, at March 31, 2019 and December 31, 2018, respectively, as presented in the RMBS, CMBS and ABS sections below.
RMBS
The following table presents our RMBS holdings at:
 
 
March 31, 2019
 
December 31, 2018
 
 
Estimated
Fair Value
 
% of
Total
 
Net Unrealized Gains (Losses)
 
Estimated
Fair Value
 
% of
Total
 
Net Unrealized Gains (Losses)
 
 
(Dollars in millions)
By security type:
 
 
 
 
 
 
 
 
 
 
 
 
Collateralized mortgage obligations
 
$
4,877

 
54.9
%
 
$
242

 
$
4,885

 
57.2
%
 
$
174

Pass-through securities
 
4,006

 
45.1

 
(7
)
 
3,662

 
42.8

 
(55
)
Total RMBS
 
$
8,883

 
100.0
%
 
$
235

 
$
8,547

 
100.0
%
 
$
119

By risk profile:
 
 
 
 
 
 
 
 
 
 
 
 
Agency
 
$
6,766

 
76.2
%
 
$
78

 
$
6,396

 
74.8
%
 
$
(23
)
Prime
 
227

 
2.5

 
10

 
296

 
3.5

 
10

Alt-A
 
932

 
10.5

 
89

 
938

 
11.0

 
79

Sub-prime
 
958

 
10.8

 
58

 
917

 
10.7

 
53

Total RMBS
 
$
8,883

 
100.0
%
 
$
235

 
$
8,547

 
100.0
%
 
$
119

Ratings profile:
 
 
 
 
 
 
 
 
 
 
 
 
Rated Aaa/AAA
 
$
6,842

 
77.0
%
 
 
 
$
6,529

 
76.4
%
 
 
Designated NAIC 1
 
$
8,754

 
98.5
%
 
 
 
$
8,395

 
98.2
%
 
 
Historically, we have managed our exposure to sub-prime RMBS holdings by focusing primarily on senior tranche securities, stress testing the portfolio with severe loss assumptions and closely monitoring the performance of the portfolio. Our sub-prime RMBS portfolio consists predominantly of securities that were purchased after 2012 at significant discounts to par value and discounts to the expected principal recovery value of these securities. The vast majority of these securities are investment grade under the NAIC designations (e.g., NAIC 1 and NAIC 2). The estimated fair value of our sub-prime RMBS holdings purchased since 2012 was $908 million and $883 million at March 31, 2019 and December 31, 2018, respectively, with unrealized gains (losses) of $54 million and $50 million at March 31, 2019 and December 31, 2018, respectively.

65

CMBS
Our CMBS holdings are diversified by vintage year. The following tables present our CMBS holdings by vintage year at:
 
 
March 31, 2019
 
December 31, 2018
 
 
Amortized Cost
 
Estimated
Fair Value
 
Amortized Cost
 
Estimated
Fair Value
 
 
(Dollars in millions)
2003 - 2010
 
$
170

 
$
175

 
$
177

 
$
177

2011
 
294

 
292

 
297

 
293

2012
 
242

 
244

 
263

 
262

2013
 
283

 
288

 
290

 
290

2014
 
446

 
451

 
526

 
519

2015
 
989

 
997

 
1,076

 
1,059

2016
 
544

 
544

 
582

 
568

2017
 
665

 
677

 
696

 
686

2018
 
1,586

 
1,646

 
1,385

 
1,394

2019
 
111

 
113

 
—

 
—

Total
 
$
5,330

 
$
5,427

 
$
5,292

 
$
5,248

CMBS rated Aaa using rating agency ratings were $3.7 billion, or 68.2% of total CMBS, and designated NAIC 1 were $5.3 billion, or 98.1% of total CMBS, at March 31, 2019. CMBS rated Aaa using rating agency ratings were $3.5 billion, or 66.9% of total CMBS, and designated NAIC 1 were $5.2 billion, or 98.8% of total CMBS at December 31, 2018.
ABS
Our ABS are diversified both by collateral type and by issuer. The following table presents our ABS holdings at:
 
March 31, 2019
 
December 31, 2018
 
Estimated
Fair Value
 
% of
Total
 
Net Unrealized
Gains (Losses)
 
Estimated
Fair Value
 
% of
Total
 
Net Unrealized
Gains (Losses)
 
(Dollars in millions)
By collateral type:
 
 
 
 
 
 
 
 
 
 
 
Collateralized obligations
$
1,089

 
52.4
%
 
$
(9
)
 
$
1,010

 
47.5
%
 
$
(18
)
Automobile loans
184

 
8.9

 
1

 
199

 
9.4

 
—

Consumer loans
167

 
8.0

 
2

 
193

 
9.1

 
1

Student loans
210

 
10.1

 
3

 
186

 
8.7

 
3

Credit card loans
36

 
1.7

 
2

 
136

 
6.4

 
2

Other loans
392

 
18.9

 
4

 
402

 
18.9

 
3

Total
$
2,078

 
100.0
%
 
$
3

 
$
2,126

 
100.0
%
 
$
(9
)
Ratings profile:
 
 
 
 
 
 
 
 
 
 
 
Rated Aaa/AAA
$
827

 
39.8
%
 
 
 
$
956

 
45.0
%
 
 
Designated NAIC 1
$
1,747

 
84.1
%
 
 
 
$
1,851

 
87.1
%
 
 
Evaluation of Fixed Maturity Securities AFS for OTTI and Evaluating Temporarily Impaired Fixed Maturity Securities AFS
See Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements for information about the evaluation of fixed maturity securities AFS and equity securities for OTTI and evaluation of temporarily impaired AFS securities.
Securities Lending
We participate in a securities lending program whereby securities are loaned to third parties, primarily brokerage firms and commercial banks. We obtain collateral, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, which is obtained at the inception of a loan and maintained at a level greater than or equal to 100% for the duration of the loan. We monitor the estimated fair value of the securities loaned on a daily basis with additional collateral obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or repledged by the

66

transferee. We are liable to return to our counterparties the cash collateral under our control. Security collateral received from counterparties may not be sold or repledged, unless the counterparty is in default, and is not reflected in the financial statements. These transactions are treated as financing arrangements and the associated cash collateral liability is recorded at the amount of the cash received.
See “— Liquidity and Capital Resources — The Company — Primary Uses of Liquidity and Capital — Securities Lending” and Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding our securities lending program.
Mortgage Loans
Our mortgage loans are principally collateralized by commercial, agricultural and residential properties. Mortgage loans and the related valuation allowances are summarized as follows at:
 
March 31, 2019
 
December 31, 2018
 
Recorded
Investment
 
% of
Total
 
Valuation
Allowance
 
% of
Recorded
Investment
 
Recorded
Investment
 
% of
Total
 
Valuation
Allowance
 
% of
Recorded
Investment
 
(Dollars in millions)
Commercial
$
8,748

 
60.0
%
 
$
43

 
0.5
%
 
$
8,529

 
62.0
%
 
$
42

 
0.5
%
Agricultural
3,155

 
21.7
%
 
9

 
0.3
%
 
2,946

 
21.4
%
 
9

 
0.3
%
Residential
2,661

 
18.3
%
 
8

 
0.3
%
 
2,276

 
16.6
%
 
6

 
0.3
%
Total
$
14,564

 
100.0
%
 
$
60

 
0.4
%
 
$
13,751

 
100.0
%
 
$
57

 
0.4
%
We diversify our mortgage loan portfolio by both geographic region and property type to reduce the risk of concentration. The percentage of our commercial and agricultural mortgage loan portfolios collateralized by properties located in the U.S. were 96% and 97% at March 31, 2019 and December 31, 2018, respectively, and the remainder was collateralized by properties located outside of the U.S. The carrying value as a percentage of total commercial and agricultural mortgage loans for the top three states in the U.S. is as follows at:
 
 
March 31, 2019
 
December 31, 2018
State
 
 
 
 
California
 
25
%
 
26
%
New York
 
14
%
 
14
%
Texas
 
8
%
 
8
%
Additionally, we manage risk when originating commercial and agricultural mortgage loans by generally lending up to 75% of the estimated fair value of the underlying real estate collateral.
We manage our residential mortgage loan portfolio in a similar manner to reduce risk of concentration. All residential mortgage loans were collateralized by properties located in the U.S. at both March 31, 2019 and December 31, 2018. The carrying value as a percentage of total residential mortgage loans for the top three states in the U.S. is as follows at:
 
 
March 31, 2019
 
December 31, 2018
State
 
 
 
 
California
 
36
%
 
36
%
Florida
 
9
%
 
9
%
New York
 
7
%
 
6
%

67

Commercial Mortgage Loans by Geographic Region and Property Type. Commercial mortgage loans are the largest component of the mortgage loan invested asset class. The tables below present the diversification across geographic regions and property types of commercial mortgage loans at:
 
March 31, 2019
 
December 31, 2018
 
Amount
 
% of
Total
 
Amount
 
% of
Total
 
(Dollars in millions)
Region
 
 
 
 
 
 
 
Pacific
$
2,579

 
29.5
%
 
$
2,550

 
29.9
%
Middle Atlantic
1,815

 
20.7

 
1,867

 
21.9

South Atlantic
1,328

 
15.2

 
1,316

 
15.5

West South Central
809

 
9.2

 
801

 
9.4

Mountain
527

 
6.0

 
404

 
4.7

East North Central
522

 
6.0

 
473

 
5.5

International
440

 
5.0

 
389

 
4.5

New England
396

 
4.5

 
397

 
4.7

West North Central
127

 
1.5

 
127

 
1.5

East South Central
59

 
0.7

 
59

 
0.7

Multi-Region and Other
146

 
1.7

 
146

 
1.7

Total recorded investment
8,748

 
100.0
%
 
8,529

 
100.0
%
Less: valuation allowances
43

 
 
 
42

 
 
Carrying value, net of valuation allowances
$
8,705

 
 
 
$
8,487

 
 
Property Type
 
 
 
 
 
 
 
Office
$
3,705

 
42.4
%
 
$
3,810

 
44.6
%
Retail
2,130

 
24.3

 
2,064

 
24.2

Apartment
1,551

 
17.7

 
1,480

 
17.4

Hotel
852

 
9.7

 
744

 
8.7

Industrial
399

 
4.6

 
400

 
4.7

Other
111

 
1.3

 
31

 
0.4

Total recorded investment
8,748

 
100.0
%
 
8,529

 
100.0
%
Less: valuation allowances
43

 
 
 
42

 
 
Carrying value, net of valuation allowances
$
8,705

 
 
 
$
8,487

 
 
Mortgage Loan Credit Quality — Monitoring Process. Our investment manager monitors our mortgage loan investments on an ongoing basis, including a review of loans that are current, past due, restructured and under foreclosure. Quarterly, we conduct a formal review of the portfolio with our investment manager. See Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements for information on mortgage loans by credit quality indicator, past due and nonaccrual mortgage loans, as well as impaired mortgage loans.
Our investment manager reviews our commercial mortgage loans on an ongoing basis. These reviews may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar, with a focus on higher risk loans, such as loans with higher loan-to-value ratios, including reviews on a geographic and sector basis. We review our residential mortgage loans on an ongoing basis. See Note 6 of the Notes to Consolidated and Combined Financial Statements included in the 2018 Annual Report for information on our evaluation of residential mortgage loans and related valuation allowance methodology.

68

Loan-to-value ratios and debt service coverage ratios are common measures in the assessment of the quality of commercial mortgage loans. Loan-to-value ratios are a common measure in the assessment of the quality of agricultural mortgage loans. Loan-to-value ratios compare the amount of the loan to the estimated fair value of the underlying collateral. A loan-to-value ratio greater than 100% indicates that the loan amount is greater than the collateral value. A loan-to-value ratio of less than 100% indicates an excess of collateral value over the loan amount. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. For our commercial mortgage loans, our average loan-to-value ratio was 52% at both March 31, 2019 and December 31, 2018, and our average debt service coverage ratio was 2.2x at both March 31, 2019 and December 31, 2018. The debt service coverage ratio, as well as the values utilized in calculating the ratio, is updated annually on a rolling basis, with a portion of the portfolio updated each quarter. In addition, the loan-to-value ratio is routinely updated for all but the lowest risk loans as part of our ongoing review of our commercial mortgage loan portfolio. For our agricultural mortgage loans, our average loan-to-value ratio was 47% and 46% at March 31, 2019 and December 31, 2018, respectively. The values utilized in calculating the agricultural mortgage loan loan-to-value ratio are developed in connection with the ongoing review of the agricultural loan portfolio and are routinely updated.
Mortgage Loan Valuation Allowances. See Notes 4 and 6 of the Notes to the Interim Condensed Consolidated Financial Statements for information about how valuation allowances are established and monitored, activity in and balances of the valuation allowance, and the estimated fair value of impaired mortgage loans and related impairments included within net investment gains (losses) at and for the three months ended March 31, 2019 and 2018.
Real Estate Limited Partnerships and Limited Liability Companies
Real estate limited partnerships and limited liability companies are comprised primarily of limited partner interests in real estate funds, and to a lesser extent interests in projects with varying strategies ranging from the development of properties to the operation of income-producing properties.
The estimated fair value of the associated investment portfolios was $568 million and $572 million at March 31, 2019 and December 31, 2018, respectively.
Other Limited Partnership Interests
Other limited partnership interests are comprised primarily of private equity funds. The carrying value of other limited partnership interests was $1.8 billion at both March 31, 2019 and December 31, 2018, which included $65 million and $98 million of hedge funds at March 31, 2019 and December 31, 2018, respectively. Cash distributions on these investments are generated from investment gains, operating income from the underlying investments of the funds and liquidation of the underlying investments of the funds. We estimate that the underlying investments of the funds will typically be liquidated over the next 10 to 20 years.
Other Invested Assets
The following table presents the carrying value of our other invested assets by type at:
 
 
 
March 31, 2019
 
December 31, 2018
 
 
 
Carrying
Value
 
% of
Total
 
Carrying
Value
 
% of
Total
 
 
 
 
(Dollars in millions)
 
Freestanding derivatives with positive estimated fair values
 
$
2,073

 
90.0
%
 
$
2,778

 
91.8
%
 
Tax credit and renewable energy partnerships
 
99

 
4.3

 
95

 
3.1

 
Leveraged leases, net of non-recourse debt
 
65

 
2.8

 
65

 
2.1

 
FHLB Stock
 
50

 
2.2

 
64

 
2.1

 
Other
 
15

 
0.7

 
25

 
0.9

 
Total
 
$
2,302

 
100.0
%
 
$
3,027

 
100.0
%
Derivatives
Derivative Risks
We are exposed to various risks relating to our ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. We use a variety of strategies to manage these risks, including the use of derivatives. See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for:
•
A comprehensive description of the nature of our derivatives, including the strategies for which derivatives are used in managing various risks.

69

•
Information about the gross notional amount, estimated fair value, and primary underlying risk exposure of our derivatives by type of hedge designation, excluding embedded derivatives, held at March 31, 2019 and December 31, 2018.
•
The statement of operations effects of derivatives in cash flow, fair value, or nonqualifying hedge relationships for the three months ended March 31, 2019 and 2018.
See “Business — Segments and Corporate & Other — Annuities,” “Business — Risk Management Strategies — ULSG Market Risk Exposure Management” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations — Annual Actuarial Review” included in the 2018 Annual Report for more information about our use of derivatives by major hedge programs.
Fair Value Hierarchy
See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for derivatives measured at estimated fair value on a recurring basis and their corresponding fair value hierarchy.
The valuation of Level 3 derivatives involves the use of significant unobservable inputs and generally requires a higher degree of management judgment or estimation than the valuations of Level 1 and Level 2 derivatives. Although Level 3 inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such instruments and are considered appropriate given the circumstances. The use of different inputs or methodologies could have a material effect on the estimated fair value of Level 3 derivatives and could materially affect net income.
Derivatives categorized as Level 3 at March 31, 2019 include: credit default swaps priced using unobservable credit spreads, or that are priced through independent broker quotations; equity variance swaps with unobservable volatility inputs; foreign currency swaps with certain unobservable inputs and equity index options with unobservable correlation inputs.
See Note 6 of the Notes to Interim Condensed Consolidated Financial Statements for a rollforward of the fair value measurements for derivatives measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs.
Credit Risk
See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for information about how we manage credit risk related to derivatives and for the estimated fair value of our net derivative assets and net derivative liabilities after the application of master netting agreements and collateral.
Our policy is not to offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. This policy applies to the recognition of derivatives in the balance sheets, and does not affect our legal right of offset.
Credit Derivatives
The following tables present the gross notional amount and estimated fair value of credit default swaps at:
 
 
March 31, 2019
 
December 31, 2018
Credit Default Swaps
 
Gross Notional Amount
 
Estimated
Fair Value
 
Gross Notional
Amount
 
Estimated
Fair Value
 
 
(In millions)
Purchased
 
$
67

 
$
—

 
$
98

 
$
3

Written
 
1,855

 
25

 
1,820

 
11

Total
 
$
1,922

 
$
25

 
$
1,918

 
$
14

The maximum amount at risk related to our written credit default swaps is equal to the corresponding gross notional amount. In a replication transaction, we pair an asset on our balance sheet with a written credit default swap to synthetically replicate a corporate bond, a core asset holding of life insurance companies. Replications are entered into in accordance with the guidelines approved by state insurance regulators and the NAIC and are an important tool in managing the overall corporate credit risk within the Company. In order to match our long-dated insurance liabilities, we seek to buy long-dated corporate bonds. In some instances, these may not be readily available in the market, or they may be issued by corporations to which we already have significant corporate credit exposure. For example, by purchasing Treasury bonds (or other high-quality assets) and associating them with written credit default swaps on the desired corporate credit name, we can replicate the desired bond exposures and meet our ALM needs. This can expose the Company to changes in credit spreads as the written credit default swap tenor is shorter than the maturity of Treasury bonds.

70


Embedded Derivatives
See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for information about the nonperformance risk adjustment included in the valuation of guaranteed minimum benefits accounted for as embedded derivatives.
See Note 6 of the Notes to the Interim Condensed Consolidated Financial Statements for information about embedded derivatives measured at estimated fair value on a recurring basis and their corresponding fair value hierarchy.
See Note 6 of the Notes to the Interim Condensed Consolidated Financial Statements for a rollforward of the fair value measurements for embedded derivatives measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs.
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates — Derivatives” included in the 2018 Annual Report for further information on the estimates and assumptions that affect embedded derivatives.
Off-Balance Sheet Arrangements
Collateral for Securities Lending and Derivatives
We have a securities lending program for the purpose of enhancing the total return on our investment portfolio. Periodically we receive non-cash collateral for securities lending from counterparties, which cannot be sold or repledged, and which is not recorded on our consolidated balance sheets. The amount of this collateral was $36 million and $55 million at estimated fair value at March 31, 2019 and December 31, 2018, respectively. See Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements, as well as “— Investments — Securities Lending” for discussion of our securities lending program, the classification of revenues and expenses, and the nature of the secured financing arrangement and associated liability.
We enter into derivatives to manage various risks relating to our ongoing business operations. We have non-cash collateral from counterparties for derivatives, which can be sold or repledged subject to certain constraints, and which has not been recorded on our consolidated balance sheets. The amount of this non-cash collateral was $275 million and $145 million at March 31, 2019 and December 31, 2018, respectively. See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding the earned income on and the gross notional amount, estimated fair value of assets and liabilities and primary underlying risk exposure of our derivatives.
Guarantees
See “Guarantees” in Note 11 of the Notes to the Interim Condensed Consolidated Financial Statements.
Other
Additionally, we enter into commitments for the purpose of enhancing the total return on our investment portfolio: mortgage loan commitments and commitments to fund partnership investments, bank credit facilities and private corporate bond investments. See “Net Investment Income” and “Net Investment Gains (Losses)” in Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements for information on the investment income, investment expense, gains and losses from such investments. See also “— Investments — Fixed Maturity AFS” and “— Investments — Mortgage Loans” for information on our investments in fixed maturity securities and mortgage loans. See “— Investments — Real Estate Limited Partnerships and Limited Liability Companies” and “— Investments — Other Limited Partnership Interests” for information on our partnership investments.
Other than the commitments disclosed in Note 11 of the Notes to the Interim Condensed Consolidated Financial Statements, there are no other material obligations or liabilities arising from the commitments to fund mortgage loans, partnership investments, bank credit facilities and private corporate bond investments. For further information on commitments to fund partnership investments, mortgage loans, bank credit facilities and private corporate bond investments, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Company — Contractual Obligations” included in the 2018 Annual Report.
Policyholder Liabilities
We establish, and carry as liabilities, actuarially determined amounts that are calculated to meet policy obligations or to provide for future annuity payments. Amounts for actuarial liabilities are computed and reported in the financial statements in conformity with GAAP. For more details on Policyholder Liabilities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” and “Management’s Discussion and Analysis of Financial

71

Condition and Results of Operations — Policyholder Liabilities” included in the 2018 Annual Report. Except as otherwise discussed below, there have been no material changes to our actuarial liabilities.
Future Policy Benefits
We establish liabilities for amounts payable under insurance policies. See Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements. A discussion of future policy benefits by segment, as well as Corporate & Other, can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Policyholder Liabilities” included in the 2018 Annual Report.
Policyholder Account Balances
Policyholder account balances (“PABs”) are generally equal to the account value, which includes accrued interest credited, but excludes the impact of any applicable charge that may be incurred upon surrender. See Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements. A discussion of PABs by segment, as well as Corporate & Other, can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Policyholder Liabilities” included in the 2018 Annual Report.
Variable Annuity Guarantees
We issue certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the Benefit Base) less withdrawals. In some cases, the Benefit Base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups. See Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements. See also “Quantitative and Qualitative Disclosures About Market Risk — Market Risk - Fair Value Exposures — Interest Rates” and “Business — Segments and Corporate & Other — Annuities — Current Products — Variable Annuities” included in the 2018 Annual Report for additional information.
Select information that management considers relevant to understanding our variable annuity risk management strategy has been included below.
Net Amount at Risk
The net amount at risk (“NAR”) for the GMDB is the amount of death benefit in excess of the account value (if any) at the balance sheet date. It represents the amount of the claim we would incur if death claims were made on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.
The NAR for the guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum accumulation benefits (“GMAB”) is the amount of guaranteed benefits in excess of the account values (if any) at the balance sheet date. The NAR assumes utilization of benefits by all contract holders at the balance sheet date. For the GMWB benefits, only a small portion of the Benefit Base is available for withdrawal on an annual basis. For the GMAB, the NAR would not be available until the GMAB maturity date.
The NAR for the GMWB with lifetime payments (“GMWB4L”) is the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream based on current annuity rates, equal to the lifetime amount provided under the guaranteed benefit. For contracts where the GMWB4L provides for a guaranteed cumulative dollar amount of payments, the NAR is based on the purchase of a lifetime with period certain income stream where the period certain ensures payment of this cumulative dollar amount. The NAR represents our potential economic exposure to such guarantees in the event all contract holders were to begin lifetime withdrawals on the balance sheet date regardless of age. Only a small portion of the Benefit Base is available for withdrawal on an annual basis.
The NAR for the GMIB is the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents our potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the guaranteed amount under the contracts may not be annuitized until after the waiting period of the contract.
A detailed description of NAR by type of guaranteed minimum benefit can be found in “Business — Segments and Corporate & Other — Annuities — Net Amount at Risk” included in the 2018 Annual Report.

72

The account values and NAR of contract owners by type of guaranteed minimum benefit for variable annuity contracts are summarized below at:
 
March 31, 2019 (1)
 
December 31, 2018 (1)
 
Account Value
 
Death Benefit NAR (1)
 
Living Benefit NAR (1)
 
% of Account Value In-the-Money (2)
 
Account Value
 
Death Benefit NAR (1)
 
Living Benefit NAR (1)
 
% of Account Value In-the-Money (2)
 
(Dollars in millions)
GMIB
$
41,149

 
$
2,655

 
$
3,294

 
30.4
%
 
$
38,682

 
$
4,064

 
$
4,115

 
42.6
%
GMIB Max w/ Enhanced DB
11,649

 
3,032

 
6

 
0.6
%
 
10,961

 
3,775

 
11

 
1.3
%
GMIB Max w/o Enhanced DB
6,709

 
9

 
1

 
0.2
%
 
6,324

 
87

 
2

 
0.42
%
GMWB4L (FlexChoiceSM)
3,217

 
12

 
2

 
2.9
%
 
2,819

 
100

 
15

 
12.5
%
GMAB
641

 
4

 
4

 
16.2
%
 
600

 
17

 
16

 
27.3
%
GMWB
2,839

 
54

 
21

 
14.8
%
 
2,672

 
143

 
85

 
31.3
%
GMWB4L
15,395

 
117

 
273

 
14.3
%
 
14,596

 
558

 
505

 
27.8
%
EDB Only
3,657

 
723

 
—

 
N/A

 
3,434

 
955

 
—

 
N/A

GMDB Only (Other than EDB)
17,892

 
1,037

 
—

 
N/A

 
16,777

 
1,374

 
—

 
N/A

Total
$
103,148

 
$
7,643

 
$
3,601

 
 
 
$
96,865

 
$
11,073

 
$
4,749

 
 
__________
(1)
The “Death Benefit NAR” and “Living Benefit NAR” are not additive at the contract level.
(2)
In-the-money is defined as any contract with a living benefit NAR in excess of zero.

73

Reserves
Under GAAP, certain of our variable annuity guarantee features are accounted for as insurance liabilities and recorded on the balance sheet in future policy benefits with changes reported in policyholder benefits and claims. These liabilities are accounted for using long term assumptions of equity and bond market returns and the level of interest rates. Therefore, these liabilities, valued at $4.7 billion at March 31, 2019, are less sensitive than derivative instruments to periodic changes to equity and fixed income market returns and the level of interest rates. Guarantees accounted for in this manner include GMDBs, as well as the life contingent portion of GMIBs and certain GMWBs. All other variable annuity guarantee features are accounted for as embedded derivatives and recorded on the balance sheet in PABs with changes reported in net derivative gains (losses). These liabilities, valued at $1.0 billion at March 31, 2019, are accounted for at fair value. Guarantees accounted for in this manner include GMABs, GMWBs and the non-life contingent portions of GMIBs. In some cases, a guarantee will have multiple features or options that require separate accounting such that the guarantee is not fully accounted for under only one of the accounting models (known as “split accounting”). Additionally, the index protection and accumulation features of Shield Annuities are accounted for as embedded derivatives, recorded on the balance sheet in PABs with changes reported in net derivative gains (losses) and valued at $1.2 billion at March 31, 2019. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” included in the 2018 Annual Report.
The table below presents the GAAP variable annuity reserve balances by guarantee type and accounting model at:
 
Reserves
 
March 31, 2019
 
December 31, 2018
 
Future Policy Benefits
 
Policyholder Account Balances
 
Total Reserves
 
Future Policy Benefits
 
Policyholder Account Balances
 
Total Reserves
 
(In millions)
GMDB
$
1,305

 
$
—

 
$
1,305

 
$
1,305

 
$
—

 
$
1,305

GMIB
2,580

 
1,264

 
3,844

 
2,565

 
1,603

 
4,168

GMIB Max
514

 
(139
)
 
375

 
507

 
14

 
521

GMAB
—

 
(15
)
 
(15
)
 
—

 
(8
)
 
(8
)
GMWB
—

 
7

 
7

 
—

 
16

 
16

GMWB4L
268

 
(75
)
 
193

 
261

 
17

 
278

GMWB4L (FlexChoiceSM)
—

 
—

 
—

 
—

 
—

 
—

Total
$
4,667

 
$
1,042

 
$
5,709

 
$
4,638

 
$
1,642

 
$
6,280

Derivatives Hedging Variable Annuity Guarantees
The table below presents the gross notional amount and estimated fair value of the derivatives in our variable annuity hedging program at:
 
 
 
 
March 31, 2019
 
December 31, 2018
Primary Underlying Risk Exposure
 
Instrument Type
 
Gross Notional Amount
 
Estimated Fair Value
 
Gross Notional Amount
 
Estimated Fair Value
 
 
 
Assets
 
Liabilities
 
 
Assets
 
Liabilities
 
 
 
 
(In millions)
Interest Rate
 
Interest rate swaps
 
$
7,578

 
$
596

 
$
27

 
$
7,928

 
$
470

 
$
29

 
 
Interest rate futures
 
54

 
—

 
—

 
54

 
—

 
—

 
 
Interest rate options
 
17,000

 
173

 
24

 
10,500

 
94

 
—

Equity Market
 
Equity futures
 
—

 
—

 
—

 
170

 
—

 
—

 
 
Equity index options
 
41,073

 
751

 
1,536

 
43,985

 
1,365

 
1,202

 
 
Equity variance swaps
 
5,574

 
91

 
242

 
5,574

 
80

 
232

 
 
Equity total return swaps
 
4,550

 
—

 
219

 
3,920

 
280

 
3

 
 
Total
 
$
75,829

 
$
1,611

 
$
2,048

 
$
72,131

 
$
2,289

 
$
1,466

Period to period changes in the estimated fair value of these hedges affect our net income, as well as stockholders’ equity and these effects can be material in any given period. See “Risk Factors — Risks Related to Our Business — Our variable annuity exposure management strategy may not be effective, may result in net income volatility and may negatively affect our statutory capital” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates,” both included in the 2018 Annual Report.

74

Liquidity and Capital Resources
Our business and results of operations are materially affected by conditions in the global capital markets and the economy generally. Stressed conditions, volatility or disruptions in global capital markets, particular markets or financial asset classes can impact us adversely, in part because we have a large investment portfolio and our insurance liabilities and derivatives are sensitive to changing market factors. Changing conditions in the global capital markets and the economy may affect our financing costs and market interest rates for our debt or equity securities. For further information regarding market factors that could affect our ability to meet liquidity and capital needs, see “— Industry Trends” and “— Investments — Current Environment.”
Liquidity and Capital Management
Based upon our capitalization, expectations regarding maintaining our business mix, ratings, and funding sources available to us, we believe we have sufficient liquidity to meet business requirements under current market conditions and certain stress scenarios. Our Board of Directors and senior management are directly involved in the governance of the capital management process, including proposed changes to the annual capital plan and capital targets. We are targeting a debt-to-capital ratio commensurate with our parent company credit ratings and our insurance subsidiaries’ financial strength ratings. We continuously monitor and adjust our liquidity and capital plans in light of market conditions, as well as changing needs and opportunities.
We maintain a substantial short-term liquidity position, which was $3.2 billion and $2.2 billion at March 31, 2019 and December 31, 2018, respectively. Short-term liquidity is comprised of cash and cash equivalents and short-term investments, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include amounts received in connection with securities lending, derivatives and assets held on deposit or in trust.
An integral part of our liquidity management includes managing our level of liquid assets, which was $39.3 billion and $36.5 billion at March 31, 2019 and December 31, 2018, respectively. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include amounts received in connection with securities lending, derivatives and assets held on deposit or in trust.
The Company
Liquidity
Liquidity refers to our ability to generate adequate cash flows from our normal operations to meet the cash requirements of our operating, investing and financing activities. We determine our liquidity needs based on a rolling 12-month forecast by portfolio of invested assets which we monitor daily. We adjust the general account asset and derivatives mix and general account asset maturities based on this rolling 12-month forecast. To support this forecast, we conduct cash flow and stress testing, which reflect the impact of various scenarios, including (i) the potential increase in our requirement to pledge additional collateral or return collateral to our counterparties, (ii) a reduction in new business sales, and (iii) the risk of early contract holder and policyholder withdrawals, as well as lapses and surrenders of existing policies and contracts. We include provisions limiting withdrawal rights in many of our products, which deter the customer from making withdrawals prior to the maturity date of the product. If significant cash is required beyond our anticipated liquidity needs, we have various alternatives available depending on market conditions and the amount and timing of the liquidity need. These available alternative sources of liquidity include cash flows from operations, sales of liquid assets and funding sources including secured funding agreements, unsecured credit facilities and secured committed facilities.
Under certain adverse market and economic conditions, our access to liquidity may deteriorate, or the cost to access liquidity may increase.
Capital
We manage our capital position to maintain our financial strength and credit ratings. Our capital position is supported by our ability to generate cash flows within our insurance companies, our ability to effectively manage the risks of our businesses and our expected ability to borrow funds and raise additional capital to meet operating and growth needs in the event of adverse market and economic conditions.
We target to maintain a debt-to-capital ratio of approximately 25%, which we monitor using an average of our key leverage ratios as calculated by A.M. Best, Fitch Ratings, Moody’s Investors Service and Standard & Poor’s Global Rating. As such, we may opportunistically look to pursue additional financing over time, which may include the incurrence of additional term loans, borrowings under credit facilities, the issuance of debt, equity or hybrid securities or the refinancing of existing indebtedness. There can be no assurance that we will be able to complete any such financing transactions on terms and conditions favorable to us or at all.

75

Additionally, we intend to maintain a funding of assets in excess of the amount required to satisfy contract holder obligations across market environments in the average of the worst two percent of a set of capital markets scenarios over the life of the contracts (“CTE98”) to support our variable annuity contracts during normal market conditions and assets in excess of the amount required to satisfy contract holder obligations across market environments in the average of the worst five percent of a set of capital markets scenarios over the life of the contracts (“CTE95”) in stressed market conditions. At March 31, 2019, we held assets in excess of CTE98.
In August 2018, we authorized the repurchase of up to $200 million of our common stock. On May 3, 2019, we authorized the repurchase of up to an additional $400 million of common stock. No common stock repurchases have been made under the May 3, 2019 authorization as of May 7, 2019. Repurchases made under such authorizations may be made through open market purchases, including pursuant to 10b5-1 plans or pursuant to accelerated stock repurchase plans, from time to time at management’s discretion in accordance with applicable federal securities laws. Common stock repurchases are dependent upon several factors, including our capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of our common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors.
We do not currently anticipate declaring or paying cash dividends on our common stock. Any future declaration and payment of dividends or other distributions or returns of capital will be at the discretion of our Board of Directors and will depend on and be subject to our financial condition, results of operations, cash needs, regulatory and other constraints, capital requirements (including capital requirements of our subsidiaries), contractual restrictions and any other factors that our Board of Directors deems relevant in making such a determination. Therefore, there can be no assurance that we will pay any dividends or make other distributions or returns of capital on our common stock, or as to the amount of any such dividends, distributions or returns of capital.
Sources and Uses of Liquidity and Capital
Our primary sources and uses of liquidity and capital are summarized as follows:
 
Three Months Ended
 March 31,
 
2019
 
2018
 
(In millions)
Sources:
 
 
 
Operating activities, net
$
376

 
$
291

Changes in policyholder account balances, net
947

 
744

Changes in payables for collateral under securities loaned and other transactions, net
—

 
75

Long-term debt issued
1,000

 
—

Preferred stock issued, net of issuance costs
412

 
—

Total sources
2,735

 
1,110

Uses:
 
 
 
Investing activities, net
1,272

 
903

Changes in payables for collateral under securities loaned and other transactions, net
1,067

 
—

Long-term debt repaid
600

 
3

Treasury stock acquired in connection with share repurchases
52

 
—

Financing element on certain derivative instruments and other derivative related transactions, net
11

 
157

Other, net
14

 
16

Total uses
3,016

 
1,079

Net increase (decrease) in cash and cash equivalents
$
(281
)
 
$
31

Cash Flows from Operating Activities
The principal cash inflows from our insurance activities come from insurance premiums, annuity considerations and net investment income. The principal cash outflows are the result of various annuity and life insurance products, operating expenses and income tax, as well as interest expense. The primary liquidity concern with respect to these cash flows is the risk of early contract holder and policyholder withdrawal.

76

Cash Flows from Investing Activities
The principal cash inflows from our investment activities come from repayments of principal, proceeds from maturities and sales of investments, as well as settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments and settlements of freestanding derivatives. We typically can have a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with our ALM discipline to fund insurance liabilities. We closely monitor and manage these risks through our comprehensive investment risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption.
Cash Flows from Financing Activities
The principal cash inflows from our financing activities come from issuances of debt and equity securities, deposits of funds associated with policyholder account balances and lending of securities. The principal cash outflows come from repayments of debt, common stock repurchases, preferred stock dividends, withdrawals associated with policyholder account balances and the return of securities on loan. The primary liquidity concerns with respect to these cash flows are market disruption and the risk of early policyholder withdrawal.
Primary Sources of Liquidity and Capital
In addition to the summary description of liquidity and capital sources discussed in “— Sources and Uses of Liquidity and Capital,” the following additional information is provided regarding our primary sources of liquidity and capital:
Funding Sources
Liquidity is provided by a variety of funding sources, including secured funding agreements, unsecured credit facilities and secured committed facilities. Capital is provided by a variety of funding sources, including issuances of debt and equity securities, as well as borrowings under our credit facilities. The diversity of our funding sources enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds. Our primary funding sources include:
Preferred Stock
On March 25, 2019, BHF issued depositary shares, each representing a 1/1,000th ownership interest in a share of BHF’s perpetual 6.600% Series A non-cumulative preferred stock (the “Series A Preferred Stock”) and in the aggregate representing 17,000 shares of Series A Preferred Stock, with a stated amount of $25,000 per share, for aggregate net cash proceeds of $412 million. Under the terms of the Series A Preferred Stock, our ability to declare or pay dividends on, or purchase, redeem or otherwise acquire, shares of our common stock or shares of any other class or series of our capital stock (if any) that ranks junior to the Series A Preferred Stock will be subject to certain restrictions in the event that we do not declare and pay (or set aside) dividends on the Series A Preferred Stock for the latest completed dividend period, and our ability to declare full dividends on preferred stock that ranks equally with the Series A Preferred Stock (if any) will be subject to certain limitations in the event we declare partial dividends on the Series A Preferred Stock. See Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements.
Federal Home Loan Bank Funding Agreements, Reported in Policyholder Account Balances
Brighthouse Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Atlanta and maintains a funding agreement program with certain FHLBs. At both March 31, 2019 and December 31, 2018, Brighthouse Life Insurance Company had obligations outstanding under funding agreements with certain FHLBs of $595 million. During the three months ended March 31, 2019 and 2018, there were no issuances or repayments under such funding agreements. Activity related to these funding agreements is reported in the Run-off segment.
Farmer Mac Funding Agreements, Reported in Policyholder Account Balances
On February 1, 2019, Brighthouse Life Insurance Company entered into a funding agreement program with the Federal Agricultural Mortgage Corporation and its affiliate Farmer Mac Mortgage Securities Corporation (“Farmer Mac”), pursuant to which the parties may enter into funding agreements in an aggregate amount of up to $500 million. At March 31, 2019, there were no borrowings under this funding agreement program. Activities related to these funding agreements are reported in the Run-off segment.

77

Credit Facilities
As of March 31, 2019, we maintained a $2.0 billion unsecured revolving credit facility maturing December 2, 2021 (the “2016 Revolving Credit Facility”), all of which may be used for letters of credit and up to $1.0 billion may be used for revolving loans, and a $1.0 billion unsecured delayed draw term loan facility maturing February 1, 2024 (the “2019 Term Loan Facility”). At March 31, 2019, there were no borrowings under the 2016 Revolving Credit Facility. In February 2019, we borrowed $1.0 billion under the 2019 Term Loan Facility, terminated our former term loan facility due December 2, 2019 (the “2017 Term Loan Facility”) without penalty and repaid $600 million of borrowings outstanding under the 2017 Term Loan Facility, with the remainder of the proceeds to be used for general corporate purposes. See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements.
On May 7, 2019, BHF entered into an amended and restated revolving credit agreement (the “2019 Revolving Credit Agreement”) with respect to a $1.0 billion five-year senior unsecured revolving credit facility (the “2019 Revolving Credit Facility”), all of which may be used for revolving loans and/or letters of credit. The 2019 Revolving Credit Agreement replaces BHF’s existing $2.0 billion five-year senior unsecured revolving credit agreement, which was scheduled to mature in December 2021. See “Other Information” for additional information regarding the 2019 Revolving Credit Facility.
Committed Facilities
Repurchase Facility
In April 2018, Brighthouse Life Insurance Company entered into a secured committed repurchase facility (the “Repurchase Facility”) with a financial institution, pursuant to which Brighthouse Life Insurance Company may enter into repurchase transactions in an aggregate amount of up to $2.0 billion. The Repurchase Facility has a term ending on July 31, 2021. Under the Repurchase Facility, Brighthouse Life Insurance Company may sell certain eligible securities at a purchase price based on the market value of the securities less an applicable margin based on the types of securities sold, with a concurrent agreement to repurchase such securities at a predetermined future date (ranging from two weeks to three months) and at a price which represents the original purchase price plus interest. At March 31, 2019, there were no borrowings under the Repurchase Facility.
Reinsurance Financing Arrangement
Our reinsurance subsidiary, Brighthouse Reinsurance Company of Delaware (“BRCD”), was formed to manage our capital and risk exposures and to support our term and ULSG businesses through the use of affiliated reinsurance arrangements and related reserve financing. As of March 31, 2019, BRCD had a $10.0 billion financing arrangement with a pool of highly rated third-party reinsurers. This financing arrangement consists of credit-linked notes that each mature in 2037. At March 31, 2019, there were no borrowings under this facility, and there was $10.0 billion of funding available under this financing arrangement.
BRCD is capitalized with cash and invested assets, including funds withheld (“Minimum Initial Target Assets”) at a level that is sufficient to satisfy its future cash obligations assuming a permanent level yield curve, consistent with NAIC cash flow testing scenarios. BRCD utilizes the above referenced financing arrangement to cover the difference between full required statutory assets (i.e., XXX/AXXX reserves plus target risk margin appropriate to meet capital needs) and Minimum Initial Target Assets. An admitted deferred tax asset, if any, would also serve to reduce the amount of funding required under the above referenced financing arrangement.
Outstanding Long-term Debt
The following table summarizes our outstanding long-term debt at:
 
 
March 31, 2019
 
December 31, 2018
 
 
(In millions)
Senior notes (1)
 
$
2,968

 
$
2,968

Term loan
 
1,000

 
600

Junior subordinated debentures (1)
 
362

 
361

Other long-term debt (2)
 
34

 
34

Total long-term debt
 
$
4,364

 
$
3,963

_______________
(1)
Includes unamortized debt issuance costs and debt discount totaling $44 million and $46 million at March 31, 2019 and December 31, 2018, respectively, for senior notes and junior subordinated debentures on a combined basis.

78

(2)
Represents non-recourse debt for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment companies.
Debt and Facility Covenants
The Company’s debt instruments and credit and committed facilities contain certain administrative, reporting and legal covenants. Additionally, the Company’s credit facilities contain financial covenants, including requirements to maintain a specified minimum adjusted consolidated net worth, to maintain a ratio of total indebtedness to total capitalization not in excess of a specified percentage and that place limitations on the dollar amount of indebtedness that may be incurred by the Company, which could restrict our operations and use of funds. At March 31, 2019, the Company was in compliance with these financial covenants.
Primary Uses of Liquidity and Capital
In addition to the summarized description of liquidity and capital uses discussed in “— Sources and Uses of Liquidity and Capital,” the following additional information is provided regarding our primary uses of liquidity and capital:
Common Stock Repurchases
During the three months ended March 31, 2019, we repurchased 1,417,582 shares of our common stock through open market purchases, pursuant to a 10b5-1 plan, for $52 million.
Debt Repurchases
We may from time to time seek to retire or purchase our outstanding indebtedness through cash purchases and/or exchanges for other securities, purchases in the open market, privately negotiated transactions or otherwise. Any such repurchases or exchanges will be dependent upon several factors, including our liquidity requirements, contractual restrictions, general market conditions, and applicable regulatory, legal and accounting factors. Whether or not we repurchase any debt and the size and timing of any such repurchases will be determined at our discretion.
Insurance Liabilities
Liabilities arising from our insurance activities primarily relate to benefit payments under various annuity and life insurance products, as well as payments for policy surrenders, withdrawals and loans. Surrender or lapse behavior differs somewhat by product but tends to occur in the ordinary course of business. During the three months ended March 31, 2019 and 2018, general account surrenders and withdrawals totaled $740 million and $729 million, respectively, of which $615 million and $449 million, respectively, were attributable to products within the Annuities segment.
Pledged Collateral
We pledge collateral to, and have collateral pledged to us by, counterparties in connection with our derivatives. At March 31, 2019 and December 31, 2018, counterparties were obligated to return cash collateral pledged by us of $15 million and $64 million, respectively. At March 31, 2019 and December 31, 2018, we were obligated to return cash collateral pledged to us by counterparties of $583 million and $1.4 billion, respectively. See Note 5 of the Notes to the Interim Condensed Consolidated Financial Statements for additional information about pledged collateral. We also pledge collateral from time to time in connection with funding agreements.
Securities Lending
We have a securities lending program whereby securities are loaned to third parties, primarily brokerage firms and commercial banks. We obtain collateral, usually cash, from the borrower, which must be returned to the borrower when the loaned securities are returned to us. Under our securities lending program, we were liable for cash collateral under our control of $3.4 billion and $3.6 billion at March 31, 2019 and December 31, 2018, respectively. Of these amounts, $1.6 billion and $1.5 billion at March 31, 2019 and December 31, 2018, respectively, were on open, meaning that the related loaned security could be returned to us on the next business day requiring the immediate return of cash collateral we hold. The estimated fair value of the securities on loan related to the cash collateral on open at March 31, 2019 was $1.5 billion, all of which were U.S. government and agency securities which, if put back to us, could be immediately sold to satisfy the cash requirement. See Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements.

79

Litigation
Putative or certified class action litigation and other litigation, and claims and assessments against us, in addition to those discussed elsewhere herein and those otherwise provided for in the financial statements, have arisen in the course of our business, including, but not limited to, in connection with our activities as an insurer, employer, investor, investment advisor, and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning our compliance with applicable insurance and other laws and regulations. See Note 11 of the Notes to the Interim Condensed Consolidated Financial Statements.

80

The Parent Company
Liquidity and Capital
In evaluating liquidity, it is important to distinguish the cash flow needs of the parent company from the cash flow needs of the combined group of companies. BHF is largely dependent on cash flows from its insurance subsidiaries to meet its obligations. Constraints on BHF’s liquidity may occur as a result of operational demands and/or as a result of compliance with regulatory requirements.
Short-term Liquidity and Liquid Assets
At March 31, 2019 and December 31, 2018, BHF and certain of its non-insurance subsidiaries had short-term liquidity of $881 million and $520 million, respectively. Short-term liquidity is comprised of cash and cash equivalents and short-term investments.
At March 31, 2019 and December 31, 2018, BHF and certain of its non-insurance subsidiaries had liquid assets of $1.1 billion and $752 million, respectively, of which $1.0 billion and $693 million, respectively, was held by BHF. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities.
Statutory Capital and Dividends
The NAIC and state insurance departments have established regulations that provide minimum capitalization requirements based on risk-based capital (“RBC”) formulas for insurance companies. RBC is based on a formula calculated by applying factors to various asset, premium, claim, expense and statutory reserve items. The formula takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk, market risk and business risk and is calculated on an annual basis. The formula is used as an early warning regulatory tool to identify possible inadequately capitalized insurers for purposes of initiating regulatory action, and not as a means to rank insurers generally. State insurance laws provide insurance regulators the authority to require various actions by, or take various actions against, insurers whose total adjusted capital (“TAC”) does not meet or exceed certain RBC levels. As of the date of the most recent annual statutory financial statements filed with insurance regulators, the TAC of each of our insurance subsidiaries subject to these requirements was in excess of each of those RBC levels.
The amount of dividends that our insurance subsidiaries can ultimately pay to BHF through their various parent entities provides an additional margin for risk protection and investment in our businesses. Such dividends are constrained by the amount of surplus our insurance subsidiaries hold to maintain their ratings, which is generally higher than minimum RBC requirements. We proactively take actions to maintain capital consistent with these ratings objectives, which may include adjusting dividend amounts and deploying financial resources from internal or external sources of capital. Certain of these activities may require regulatory approval. Furthermore, the payment of dividends and other distributions by our insurance subsidiaries is governed by insurance laws and regulations. See “— Primary Sources and Uses of Liquidity and Capital — Dividends and Returns of Capital from Insurance Subsidiaries.”
Primary Sources and Uses of Liquidity and Capital
The principal sources of funds available to BHF include distributions from Brighthouse Holdings, LLC (“BH Holdings”), dividends and returns of capital from its insurance subsidiaries, capital markets issuances, as well as its own cash and cash equivalents and short-term investments. These sources of funds may also be supplemented by alternate sources of liquidity either directly or indirectly through our insurance subsidiaries. For example, we have established internal liquidity facilities to provide liquidity within and across our regulated and non-regulated entities to support our businesses.
The primary uses of liquidity of BHF include debt service including interest expense and debt repayments, capital contributions to subsidiaries, common stock repurchases and payment of general operating expenses. Based on our analysis and comparison of our current and future cash inflows from the dividends we receive from subsidiaries that are permitted to be paid without prior insurance regulatory approval, our investment portfolio and other cash flows and anticipated access to the capital markets, we believe there will be sufficient liquidity and capital to enable BHF to make payments on debt, contribute capital to its subsidiaries, repurchase its common stock, pay all general operating expenses and meet its cash needs.

81

In addition to the liquidity and capital sources discussed in “— The Company — Primary Sources of Liquidity and Capital” and “— The Company — Primary Uses of Liquidity and Capital,” the following additional information is provided regarding BHF’s primary sources and uses of liquidity and capital:
Distributions from and Capital Contributions to BH Holdings
During the three months ended March 31, 2019 and 2018, BHF received cash distributions of $195 million and $52 million from BH Holdings. During the three months ended March 31, 2019, BHF made a cash capital contribution of $412 million to BH Holdings.
Dividends and Returns of Capital from Insurance Subsidiaries
Our business is primarily conducted through our insurance subsidiaries. The insurance subsidiaries are subject to regulatory restrictions on the payment of dividends and other distributions imposed by the regulators of their respective state domiciles.
Any requested payment of dividends by Brighthouse Life Insurance Company and New England Life Insurance Company to BH Holdings, or by Brighthouse Life Insurance Company of NY (“BHNY”) to Brighthouse Life Insurance Company, in excess of the 2019 limit on the permitted payment of dividends without approval would be considered an extraordinary dividend and would require prior approval from the Delaware Department of Insurance or the Massachusetts Division of Insurance, and the New York State Department of Financial Services, respectively.
The table below sets forth the dividends permitted to be paid in 2019 by our insurance subsidiaries without insurance regulatory approval and the respective dividends paid during the three months ended March 31, 2019.
 
 
Paid
 
Permitted without Approval (1)
 
 
(In millions)
Brighthouse Life Insurance Company
 
$
—

 
$
798

New England Life Insurance Company
 
$
—

 
$
131

Brighthouse Life Insurance Company of NY (2)
 
$
—

 
$
27

_______________
(1)
Reflects dividend amounts that may be paid during 2019 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2019, some or all of such dividends may require regulatory approval.
(2)
Dividends are not anticipated to be paid by BHNY in 2019.
Short-term Intercompany Loans
As of March 31, 2019, BHF, as borrower, had a short-term intercompany loan agreement with certain of its non-insurance subsidiaries, as lenders, for the purposes of facilitating the management of the available cash of the borrower and the lenders on a short-term and consolidated basis. Such intercompany loan agreement allows management to optimize the efficient use of and maximize the yield on cash between BHF and its subsidiary lenders. Each loan entered into under this intercompany loan agreement has a term not more than 364 days and bears interest on the unpaid principal amount at a variable rate, payable monthly. During the three months ended March 31, 2019 and 2018, BHF borrowed $188 million and $0, respectively, from certain of its non-insurance subsidiaries under short-term intercompany loan agreements and repaid $384 million and $57 million, respectively, to certain of its non-insurance company subsidiaries under short-term intercompany loan agreements. At March 31, 2019 and December 31, 2018, BHF had total obligations outstanding of $107 million and $303 million, respectively, under such agreements.
Intercompany Liquidity Facilities
As of March 31, 2019, we maintained intercompany liquidity facilities with certain of our insurance and non-insurance company subsidiaries to provide short-term liquidity within and across the combined group of companies. Under these facilities, which are comprised of a series of revolving loan agreements among BHF and its participating subsidiaries, each company may lend to or borrow from each other, subject to certain maximum limits for a term not more than 364 days. During the three months ended March 31, 2019 and 2018, there were no borrowings under intercompany liquidity facilities and, at March 31, 2019 and December 31, 2018, there were no obligations outstanding under such facilities.

82

Note Regarding Forward-Looking Statements
This report, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as “anticipate,” “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operating and financial results, as well as statements regarding the expected benefits of the Separation.
Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of Brighthouse. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others:
•differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models;
•
higher risk management costs and exposure to increased market and counterparty risk due to guarantees within certain of our products;
•
the effectiveness of our variable annuity exposure management strategy and the impact of such strategy on net income volatility and negative effects on our statutory capital;
•
the reserves we are required to hold against our variable annuities as a result of actuarial guidelines;
•
a sustained period of low equity market prices and interest rates that are lower than those we assumed when we issued our variable annuity products;
•
the potential material adverse effect of changes in accounting standards, practices and/or policies applicable to us, including changes in the accounting for long duration contracts;
•
our degree of leverage due to indebtedness;
•
the effect adverse capital and credit market conditions may have on our ability to meet liquidity needs and our access to capital;
•
the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations;
•
the effectiveness of our risk management policies and procedures;
•
the availability of reinsurance and the ability of our counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder;
•
heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities and name recognition;
•
the ability of our insurance subsidiaries to pay dividends to us, and our ability to pay dividends to our shareholders;
•
our ability to market and distribute our products through distribution channels;
•
any failure of third parties to provide services we need, any failure of the practices and procedures of these third parties and any inability to obtain information or assistance we need from third parties, including MetLife;
•
whether all or any portion of the tax consequences of the Separation are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us;
•
the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements, including the potential of outcomes adverse to us that could cause us to owe MetLife material tax reimbursements or payments, or disagreements regarding MetLife’s or our obligations under our other agreements;

83

•
the impact on our business structure, profitability, cost of capital and flexibility due to restrictions we have agreed to that preserve the tax-free treatment of certain parts of the Separation;
•
the potential material negative tax impact of potential future tax legislation that could decrease the value of our tax attributes and cause other cash expenses, such as reserves, to increase materially and make some of our products less attractive to consumers;
•
whether the Separation will qualify for non-recognition treatment for federal income tax purposes and potential indemnification to MetLife if the Separation does not so qualify;
•
the impact of the Separation on our business and profitability due to MetLife’s strong brand and reputation, the increased costs related to replacing arrangements with MetLife with those of third parties and incremental costs as a public company;
•
whether the operational, strategic and other benefits of the Separation can be achieved, and our ability to implement our business strategy;
•
our ability to attract and retain key personnel; and
•
other factors described in our 2018 Annual Report and from time to time in documents that we file with the SEC.
For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our 2018 Annual Report, particularly in the sections entitled “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk,” as well as in our subsequent SEC filings. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.
Corporate Information
We routinely use our Investor Relations website to provide presentations, press releases and other information that may be deemed material to investors. Accordingly, we encourage investors and others interested in the Company to review the information that we share at http://investor.brighthousefinancial.com. Information contained on or connected to any website referenced in this report or any of our other filings with the SEC is not incorporated by reference in this report or in any other report or document we file with the SEC, and any website references are intended to be inactive textual references only unless expressly noted.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We regularly analyze our market risk exposure to interest rate, equity market price, credit spreads and foreign currency exchange rate risks. As a result of that analysis, we have determined that the estimated fair values of certain assets and liabilities are significantly exposed to changes in interest rates, and to a lesser extent, to changes in equity market prices and foreign currency exchange rates. We have exposure to market risk through our insurance and annuity operations and general account investment activities. For purposes of this discussion, “market risk” is defined as changes in fair value resulting from changes in interest rates, equity market prices, credit spreads and foreign currency exchange rates. We may have additional financial impacts other than changes in fair value, which are beyond the scope of this discussion. A description of our market risk exposures may be found under “Quantitative and Qualitative Disclosures About Market Risk” in the 2018 Annual Report. There have been no material changes to our market risk exposures from the market risk exposures previously disclosed in the 2018 Annual Report.
Item 4. Controls and Procedures
Management, with the participation of the Chief Executive Officer and Interim Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Interim Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of March 31, 2019.
MetLife provides certain services to the Company on a transitional basis through services agreements. The Company continues to change business processes, implement systems and establish new third-party arrangements. In the first quarter of 2019, the Company implemented certain accounting systems independent of MetLife. We consider these to be material changes in our internal control over financial reporting.

84

Other than as noted above, there were no changes to the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Part II — Other Information
Item 1. Legal Proceedings
 See Note 11 of the Notes to the Interim Condensed Consolidated Financial Statements included in this report. There have been no new material legal proceedings and no material developments in legal proceedings previously disclosed in the 2018 Annual Report.
Item 1A. Risk Factors
We discuss in this report, in the 2018 Annual Report and in our other filings with the SEC, various risks that may materially affect our business. In addition, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Note Regarding Forward-Looking Statements” included in this report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2018 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Purchases of BHF common stock made by or on behalf of BHF or its affiliates during the three months ended March 31, 2019 are set forth below:
Period
 
Total Number of Shares Purchased (1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)
 
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
 
 
 
 
 
 
 
 
(In millions)
January 1 — January 31, 2019
 
571,266

 
$
33.65

 
571,266

 
$
76

February 1 — February 28, 2019
 
391,835

 
$
39.49

 
391,835

 
$
60

March 1 — March 31, 2019
 
491,044

 
$
38.26

 
454,481

 
$
43

Total
 
1,454,145

 
 
 
1,417,582

 
 
__________
(1)
Where applicable, total number of shares purchased includes shares of common stock withheld with respect to option exercise costs and tax withholding obligations associated with the exercise or vesting of share-based compensation awards under our publicly announced benefit plans or programs.
(2)
On August 5, 2018, we authorized the repurchase of up to $200 million of our common stock. On May 3, 2019, we authorized the repurchase of up to an additional $400 million of our common stock. For more information on common stock repurchases, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Company — Primary Uses of Liquidity and Capital — Common Stock Repurchases” and Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements.

85

Item 5. Other Information
Entry into a Material Definitive Agreement and Creation of a Direct Financial Obligation.
On May 7, 2019, BHF entered into an amended and restated revolving credit agreement (the “2019 Revolving Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent and the other lenders party thereto with respect to a $1.0 billion five-year senior unsecured revolving credit facility (the “2019 Revolving Credit Facility”). The 2019 Revolving Credit Agreement replaces BHF’s existing $2.0 billion five-year senior unsecured revolving credit agreement, dated as of December 2, 2016, among BHF, JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders named therein (the “2016 Revolving Credit Agreement”), which was scheduled to mature in December 2021. The 2016 Revolving Credit Agreement allowed up to $2.0 billion in letters of credit but limited the amount of revolving loans to $1.0 billion. The 2019 Revolving Credit Agreement allows up to an aggregate of $1.0 billion of loans and/or letters of credit.
Availability and Prepayment
Under the 2019 Revolving Credit Facility, senior unsecured revolving loans and letters of credit will be available from time to time for our general corporate purposes up to a maximum aggregate principal amount of $1.0 billion. Provided that no default exists, BHF may request increases of the maximum available principal amount under the 2019 Revolving Credit Facility, subject to lender commitments and maximum total commitments under such facility not exceeding $1.5 billion. Subject to compliance with the applicable notice and minimum prepayment amount requirements set forth in the 2019 Revolving Credit Agreement, BHF may prepay the 2019 Revolving Credit Facility at any time without penalty. The 2019 Revolving Credit Facility will mature on May 7, 2024 (the “Maturity Date”).
Interest
Any loan made under the 2019 Revolving Credit Facility will bear interest at a rate equal to (i) the base rate (determined as the highest of (a) the Federal Reserve Bank of New York Rate plus 0.50%, (b) the prime rate last quoted in the Wall Street Journal and (c) the one month London interbank offered rate (“LIBOR”) plus 1.00%), plus an applicable margin ranging from 0.125% to 1.125% depending on the rating by S&P and Moody’s of BHF’s senior, unsecured long-term indebtedness (the “BHF Debt Rating”) or (ii) one, two, three or six month LIBOR (at BHF’s option) plus an applicable margin ranging from 1.125% to 2.125% depending on the BHF Debt Rating.
With respect to any loans accruing interest based on the base rate, interest payments are due quarterly in arrears on the last business day of each of March, June, September and December in each year and on the Maturity Date. With respect to outstanding loans accruing interest based on LIBOR, interest payments are due (i) on the last day of the applicable interest period, or, if such interest period is greater than three months, the last day of each three-month period, (ii) in the event of any conversion of loans accruing interest based on LIBOR prior to the end of the then-current interest period, on the effective date of such conversion and (iii) on the Maturity Date. While any principal of or interest on any loan is overdue, such overdue principal or interest shall accrue interest at the otherwise applicable interest rate for such loan plus 2.00% per annum.
Fees
BHF will pay customary fees with respect to the 2019 Revolving Credit Facility, including a commitment fee on the unutilized portion thereof. Commitment fees range from 0.125% to 0.350% depending on the BHF Debt Rating.
Ranking
The 2019 Revolving Credit Facility is unsecured and ranks pari passu with BHF’s other unsecured and unsubordinated indebtedness.
Events of Default; Representations and Warranties; Covenants
The 2019 Revolving Credit Agreement contains customary events of default, representations and warranties and covenants, including, among other things, covenants that restrict the ability of BHF and its subsidiaries to incur certain additional indebtedness, create or permit liens on assets, or engage in mergers or consolidations. The 2019 Revolving Credit Agreement also requires the Company to (i) maintain an Adjusted Consolidated Net Worth (as defined in the 2019 Revolving Credit Agreement) calculated as of the last day of each fiscal quarter, of not less than an amount equal to the sum of (A) 72% of the actual Adjusted Consolidated Net Worth of the Company (determined as of the end of the first fiscal quarter ending after August 4, 2017 (the date of the Company’s separation from its former parent company)) plus (B) 50% of the aggregate amount of equity issuances by BHF and its subsidiaries and the equity credit portion of securities given some equity credit by certain ratings agencies after the end of the first fiscal quarter ending following August 4, 2017, and (ii) not permit the ratio of Consolidated Total Indebtedness to Consolidated Total

86

Capitalization (each as defined in the 2019 Revolving Credit Agreement) to exceed 0.35 to 1.00, calculated as of the last day of each fiscal quarter.
If an event of default under the 2019 Revolving Credit Agreement shall occur and be continuing, the principal amount of any loans outstanding thereunder, together with all accrued unpaid interest and other amounts owed under such loans, may be declared immediately due and payable, and cash collateral in an amount equal to the then undrawn amounts of all letters of credit may be demanded by the applicable issuing banks.
The foregoing description of the 2019 Revolving Credit Agreement is qualified in its entirety by reference to the complete terms and conditions of the 2019 Revolving Credit Agreement, which is filed as Exhibit 10.8 hereto and incorporated herein by reference.
Termination of a Material Definitive Agreement.
In connection with entry into the 2019 Revolving Credit Agreement, the 2016 Revolving Credit Agreement was terminated. All obligations under the 2016 Revolving Credit Agreement are now evidenced by the 2019 Revolving Credit Agreement.

87

Item 6. Exhibits
(Note Regarding Reliance on Statements in Our Contracts: In reviewing the agreements included as exhibits herein, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Brighthouse Financial, Inc. and its subsidiaries or affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Brighthouse Financial, Inc. and its subsidiaries and affiliates may be found elsewhere herein and Brighthouse Financial, Inc.’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)

88

Exhibit
No.
 
Description
3.1
 
3.2
 
4.1
 
4.2
 
4.3
 
10.1
 
10.2
 
10.3#
 
10.4#
 
10.5#
 
10.6#
 
10.7#
 
10.8*
 
31.1*
 
31.2*
 
32.1*
 
32.2*
 
101.INS*
 
XBRL Instance Document.
101.SCH*
 
XBRL Taxonomy Extension Schema Document.
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase Document.
* Filed herewith.
# Denotes management contracts or compensation plans or arrangements.

89

Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRIGHTHOUSE FINANCIAL, INC.
 
 
 
By:
 
 
/s/ Conor E. Murphy
 
Name:
 
Conor E. Murphy
 
Title:
 
Executive Vice President, Chief Operating Officer and Interim Chief Financial Officer
 
 
 
(Authorized Signatory and Principal Financial Officer)
Date: May 7, 2019

90